Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.
A E Thigpen, … , J D McConnell, D W Russell
A E Thigpen, … , J D McConnell, D W Russell
Published August 1, 1993
Citation Information: J Clin Invest. 1993;92(2):903-910. https://doi.org/10.1172/JCI116665.
View: Text | PDF
Research Article Article has an altmetric score of 15

Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.

  • Text
  • PDF
Abstract

The synthesis of dihydrotestosterone is catalyzed by steroid 5 alpha-reductase isozymes, designated types 1 and 2. Mutation of type 2 results in male pseudohermaphroditism, in which the external genitalia are phenotypically female at birth. Two striking and unexplained features of this disorder are that external genitalia of affected males undergo virilization during puberty and that these individuals have less temporal hair regression. The tissue-specific and developmental expression patterns of the 5 alpha-reductase isozymes were investigated by immunoblotting. The type 1 isozyme is not detectable in the fetus, is transiently expressed in newborn skin and scalp, and permanently expressed in skin from the time of puberty. There was no qualitative difference in 5 alpha-reductase type 1 expression between adult balding vs. nonbalding scalp. The type 2 isozyme is transiently expressed in skin and scalp of newborns. Type 2 is the predominant isozyme detectable in fetal genital skin, male accessory sex glands, and in the prostate, including benign prostatic hyperplasia and prostate adenocarcinoma tissues. Both isozymes are expressed in the liver, but only after birth. These results are consistent with 5 alpha-reductase type 1 being responsible for virilization in type 2-deficient subjects during puberty, and suggest that the type 2 isozyme may be an initiating factor in development of male pattern baldness.

Authors

A E Thigpen, R I Silver, J M Guileyardo, M L Casey, J D McConnell, D W Russell

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1991 Total
Citations: 3 7 6 4 8 18 16 12 15 8 15 24 15 23 25 23 21 19 16 16 22 20 21 20 15 15 20 29 15 24 16 10 1 522
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (522)

Title and authors Publication Year
Aberrant Expression Levels of Androgen Receptor and SRD5A2 in Epididymal Epithelial Cells of Crossbred Infertile Cattle–Yak
Wittayarat M, Kawanishi K, Ohata H, Nagahara M, Sambuu R, Sambuu O, Hirata M, Tanihara F, Taniguchi M, Otoi T, Sato Y
Animals : an Open Access Journal from MDPI 2025
3,5-Disubstituted pyrazoline as a promising core for anticancer agents: mechanisms of action and therapeutic potentials
Gabr BS, Shalabi AR, Said MF, George RF
Future Medicinal Chemistry 2025
The 100 most cited articles in androgenetic alopecia: A bibliometric analysis
Sawar K, Mekani L, Kallabat A, Kato D, Potts GA
Medicine 2025
Finasteride delays atherosclerosis progression in mice and is associated with a reduction in plasma cholesterol in men
McQueen P, Molina D, Pinos I, Krug S, Taylor AJ, LaFrano MR, Kane MA, Amengual J
Journal of lipid research 2024
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Polyzos SA, Targher G
Current Obesity Reports 2024
Identification and characterization of dystrophin-locus-derived testis-specific protein: A testis-specific gene within the intronic region of the rat dystrophin gene
YAMANOUCHI K, KATO S, TANAKA Y, IKEDA M, OSHIMO Y, SHIGA T, HATAMOTO K, CHAMBERS J, IMAMURA T, HIRAMATSU R, UCHIDA K, MATSUDA F, MATSUWAKI T, KOHSAKA T
Journal of Reproduction and Development 2024
Current Understanding of Androgen Signaling in Prostatitis and its Treatment: A Review.
Cabeza M
Current medicinal chemistry 2024
The Etiology and Pathogenesis of Benign Prostatic Hyperplasia: The Roles of Sex Hormones and Anatomy
Xu G, Dai G, Huang Z, Guan Q, Du C, Xu X
Research and Reports in Urology 2024
Is There an Association between 5a Reductase Inhibitors and Metabolic Syndrome? A Narrative Review of the Literature.
Ziogou A, Giannakodimos A, Mitakidi E, Konstantinos T, Giannakodimos I
Reviews on recent clinical trials 2024
Steroid metabolism and hormonal dynamics in normal and malignant ovaries
Beevors LI, Sundar S, Foster PA
Essays in Biochemistry 2024
Sinomenine Hydrochloride Can Ameliorate Benign Prostatic Hyperplasia by Lowering the 5α-Reductase 2 Level and Regulating the Balance between the Proliferation and Apoptosis of Cells.
Fan MS, Xia YF, Ye RH, Sun ZR, Wang MY, An MF, Zhang SS, Zhang LJ, Zhao YL, Xiang ZM, Sheng J
Molecules (Basel, Switzerland) 2023
Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach.
Michelet R, Bindellini D, Melin J, Neumann U, Blankenstein O, Huisinga W, Johnson TN, Whitaker MJ, Ross R, Kloft C
Frontiers in pharmacology 2023
The Comprehensive Steroidome in Complete TSPO/PBR Knockout Mice under Basal Conditions.
Liere P, Liu GJ, Pianos A, Middleton RJ, Banati RB, Akwa Y
International journal of molecular sciences 2023
Ultrasound-induced cavitation renders prostate cancer cells susceptible to hyperthermia: Analysis of potential cellular and molecular mechanisms.
Hu S, Zhang X, Melzer A, Landgraf L
Frontiers in Genetics 2023
Targeting sex steroid biosynthesis for breast and prostate cancer therapy.
Poutanen M, Hagberg Thulin M, Härkönen P
Nature reviews. Cancer 2023
Two genetic variants in the SRD5A2 gene are found to be associated with sex differences in the disease characteristics of patients with chronic hepatitis B virus infection.
Duan H, Wang X, Qi W, Shi J, Han L, Wang G, Xu Y, Liu J, Wang J
Biology of sex differences 2023
Histological analysis of testes in patients with 5 alpha-reductase deficiency type 2: Comparison with cryptorchid testes in patients without endocrinological abnormalities and a review of the literature.
Wada T, Ichikawa C, Takeuchi M, Matsui F, Matsumoto F, Ida S, Etani Y, Kawai M
2022
Expression of CSF1, AR, and SRD5A2 during Postnatal Development of the Boar Reproductive Tract.
Katleba K, Legacki E, Berger T
2022
Overexpression of SRD5A3 in Hepatocellular Carcinoma and Its Molecular Mechanism: A Study of Bioinformatics Exploration Analysis with Experimental Verification.
Chen E, Yi J, Ren Q, Mi Y, Gan Z, Liu J
Evidence-based complementary and alternative medicine : eCAM 2022
In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications
Huang K, Zapata D, Tang Y, Teng Y, Li Y
Biomaterials 2022
The 5α-reductase inhibitor finasteride reduces opioid self-administration in animal models of opioid use disorder
Gabriel D. Bosse, Roberto Cadeddu, Gabriele Floris, Ryan D Farero, Eva Vigato, Suhjung Janet Lee, Tejia Zhang, Nilesh Gaikwad, Kristen Keefe, Paul Phillips, Marco Bortolato, Randall T. Peterson
Journal of Clinical Investigation 2021
Highlights on Steroidal Arylidene Derivatives as a Source of Pharmacologically Active Compounds: A Review
V Brito, G Alves, P Almeida, S Silvestre
Molecules (Basel, Switzerland) 2021
Suppression of steroid 5α-reductase type I promotes cellular apoptosis and autophagy via PI3K/Akt/mTOR pathway in multiple myeloma
R Dou, J Qian, W Wu, Y Zhang, Y Yuan, M Guo, R Wei, S Yang, A Jurczyszyn, S Janz, M Beksac, C Gu, Y Yang
Cell Death and Disease 2021
Cell culture as a toolbox to generate phase I metabolites for antidoping screening
R Savill, H Baues, E Voigt, O Zierau, D Thieme, AM Keiler
Drug Testing and Analysis 2021
5α‐reductase inhibitors: Evaluation of their potential confounding effect on GC‐C‐IRMS doping analysis
L Iannella, C Colamonici, D Curcio, F Botrè, X Torre
Drug Testing and Analysis 2021
The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studies
N Nikolaou, L Hodson, JW Tomlinson
The Journal of Steroid Biochemistry and Molecular Biology 2021
Managing patterned hair loss – a hair raising task!
A Sharma, M Shirolikar, M Mhatre
2021
The association of new-onset diabetes mellitus and medical therapy for benign prostatic hyperplasia: A population-based study.
Johnstone J, Lusty A, Tohidi M, Whitehead M, Tranmer J, Nickel JC, Siemens DR
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2021

Dihydrotestosterone Induces Proliferation, Migration, and Invasion of Human Glioblastoma Cell Lines


DC Rodríguez-Lozano, DE Velázquez-Vázquez, AD Moral-Morales, I Camacho-Arroyo
OncoTargets and therapy 2020
Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
J Robitaille, VS Langlois
General and Comparative Endocrinology 2020
The therapeutic effects of Stauntonia hexaphylla in benign prostate hyperplasia are mediated by the regulation of androgen receptors and 5α-reductase type 2
GL Hong, SR Park, DY Jung, S Karunasagara, KP Lee, EJ Koh, K Cho, SS Park, JY Jung
Journal of Ethnopharmacology 2020
Steroid 5 alpha-reductase 3 (SRD5A3) promotes tumor growth and predicts poor survival of human hepatocellular carcinoma (HCC)
Q Mai, D Sheng, C Chen, Q Gou, M Chen, X Huang, H Yin, X Chen, Z Chen
Aging 2020
Genetic Analysis of 25 Patients with 5 α -Reductase Deficiency in Chinese Population
B Han, T Cheng, H Zhu, J Yu, W Zhu, H Song, H Yao, J Qiao
BioMed Research International 2020
The Role of Androgen Signaling in Male Sexual Development at Puberty
RA Rey
Endocrinology 2020
Meta-Analysis of steroid-converting enzymes and related receptors in prostate cancer suggesting novel combined therapies
WF Zhang, T Li, SX Lin
The Journal of Steroid Biochemistry and Molecular Biology 2020
Expression in Escherichia Coli, Purification, and Functional Reconstitution of Human Steroid 5α-Reductases
HM Peng, J Valentín-Goyco, SC Im, B Han, J Liu, J Qiao, RJ Auchus
Endocrinology 2020
Progesterone in the Brain: Hormone, Neurosteroid and Neuroprotectant
R Guennoun
International journal of molecular sciences 2020
A Mechanism by which Ergosterol Inhibits the Promotion of Bladder Carcinogenesis in Rats
N Ikarashi, M Hoshino, T Ono, T Toda, Y Yazawa, K Sugiyama
Biomedicines 2020
Ultrasound-activated particles as CRISPR/Cas9 delivery system for androgenic alopecia therapy
JY Ryu, EJ Won, HA Lee, JH Kim, E Hui, HP Kim, TJ Yoon
Biomaterials 2020
Protective Role of Nutritional Plants Containing Flavonoids in Hair Follicle Disruption: A Review
E Bassino, F Gasparri, L Munaron
International journal of molecular sciences 2020
Transcriptomic analysis reveals the key regulators and molecular mechanisms underlying myometrial activation during equine placentitis†
HE Ali, YL Boakari, SC Loux, P Dini, KE Scoggin, A Esteller-Vico, T Kalbfleisch, BA Ball
Biology of reproduction 2020
Clinical characteristics and genotype‐phenotype correlations of 130 Chinese children in a high‐homogeneity single‐center cohort with 5α‐reductase 2 deficiency
L Fan, Y Song, M Polak, L Li, X Ren, B Zhang, D Wu, C Gong
Molecular Genetics & Genomic Medicine 2020
Pharmacological treatment of lower urinary tract symptoms in benign prostatic hyperplasia: consequences on sexual function and possible endocrine effects
SL Vignera, A Aversa, R Cannarella, RA Condorelli, Y Duca, GI Russo, AE Calogero
Expert Opinion on Pharmacotherapy 2020
Jean Wilson and his legacy, 50 years and counting
AP Kenigsberg, WD Tilley, GV Raj
Urology 2020
Advances in Knowledge of Androgens: How Intentional and Accidental Neurosteroid Changes Inform Us of Their Action and Role
CA Frye, D DaCosta, VF Lembo, AA Walf
Current Sexual Health Reports 2020
Association between 5α-reductase inhibitors therapy and incidence, cancer-specific mortality, and progression of prostate cancer: evidence from a meta-analysis
LM Luo, RD Yang, JM Wang, SK Zhao, YZ Liu, ZG Zhu, Q Xiang, ZG Zhao
Asian Journal of Andrology 2020
Alternative pathway androgen biosynthesis and human fetal female virilization
N Reisch, AE Taylor, EF Nogueira, DJ Asby, V Dhir, A Berry, N Krone, RJ Auchus, CH Shackleton, NA Hanley, W Arlt
Proceedings of the National Academy of Sciences 2019
Liver and Steroid Hormones—Can a Touch of p53 Make a Difference?
M Charni-Natan, R Aloni-Grinstein, E Osher, V Rotter
Frontiers in Endocrinology 2019
Growth Pattern in Chinese Children With 5α-Reductase Type 2 Deficiency: A Retrospective Multicenter Study
X Zhao, Y Song, S Chen, X Wang, F Luo, Y Yang, L Chen, R Chen, H Chen, Z Su, D Wu, C Gong
Frontiers in pharmacology 2019
Testosterone May Hold Therapeutic Promise for the Treatment ofIschemic Stroke in Aging: A Closer Look at Laboratory Findings
F Farajdokht, M Farhoudi, A Majdi, M Zamanlu, S Sadigh-Eteghad, S Vahedi, J Mahmoudi
Advanced pharmaceutical bulletin 2019
Finasteride and androgenic alopecia; from therapeutic options to medical implications
IG Motofei, DL Rowland, M Tampa, MI Sarbu, MI Mitran, CI Mitran, AP Stoian, CC Diaconu, S Paunica, SR Georgescu
Journal of Dermatological Treatment 2019
Deciphering the binding of dutasteride with human alpha-2-macroglobulin: Molecular docking and calorimetric approach
MK Zia, T Siddiqui, SS Ali, H Ahsan, FH Khan
International Journal of Biological Macromolecules 2019
The efficacy and use of finasteride in women: a systematic review
AC Hu, LW Chapman, NA Mesinkovska
International Journal of Dermatology 2019
In silico and functional studies reveal novel loss-of-function variants of SRD5A2, but no variants explaining excess 5α-reductase activity
E Katharopoulos, K Sauter, AV Pandey, CE Flück
The Journal of Steroid Biochemistry and Molecular Biology 2019
Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review
L Schiffer, L Barnard, ES Baranowski, LC Gilligan, AE Taylor, W Arlt, CH Shackleton, KH Storbeck
The Journal of Steroid Biochemistry and Molecular Biology 2019
Early embryonic exposure of freshwater gastropods to pharmaceutical 5-alpha-reductase inhibitors results in a surprising open-coiled “banana-shaped” shell
A Baynes, GM Pino, GH Duong, AE Lockyer, C McDougall, S Jobling, EJ Routledge
Scientific Reports 2019
In Vivo Effects of Polymerized Anthocyanin from Grape Skin on Benign Prostatic Hyperplasia
YJ Choi, M Fan, Y Tang, HP Yang, JY Hwang, EK Kim
Nutrients 2019
The diagnosis of androgenetic alopecia in children: Considerations of pathophysiological plausibility
A Rossi, A D'Arino, F Pigliacelli, G Caro, M Muscianese, MC Fortuna, M Carlesimo
Australasian Journal of Dermatology 2019
Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris
DH Marks, S Prasad, BD Souza, LJ Burns, MM Senna
American Journal of Clinical Dermatology 2019
New insights into 5α-reductase type 2 deficiency based on a multi-centre study: regional distribution and genotype–phenotype profiling of SRD5A2 in 190 Chinese patients
B Gui, Y Song, Z Su, FH Luo, L Chen, X Wang, R Chen, Y Yang, J Wang, X Zhao, L Fan, X Liu, Y Wang, S Chen, C Gong
Journal of medical genetics 2019
Detection of testosterone doping in female athletes
DJ Handelsman, S Bermon
Drug Testing and Analysis 2019
Identification of three novel SRD5A2 mutations in Chinese patients with 5α-reductase 2 deficiency
T Cheng, H Wang, B Han, H Zhu, HJ Yao, SX Zhao, WJ Zhu, HL Zhai, FG Chen, HD Song, KX Cheng, Y Liu, J Qiao
Asian Journal of Andrology 2019
Intracrine androgen biosynthesis, metabolism and action revisited
L Schiffer, W Arlt, KH Storbeck
Molecular and Cellular Endocrinology 2018
The impact of androgen actions in neurons on metabolic health and disease
JJ Morford, S Wu, F Mauvais-Jarvis
Molecular and Cellular Endocrinology 2018
Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase in Vivo and in Vitro
DH Youn, J Park, HL Kim, Y Jung, JW Kang, S Lim, G Song, HJ Kwak, JY Um
Frontiers in pharmacology 2018
Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
LJ Mosher, SC Godar, M Morissette, KM McFarlin, S Scheggi, C Gambarana, SC Fowler, TD Paolo, M Bortolato
Psychoneuroendocrinology 2018
Impact of anabolic androgenic steroids on sexual function
JM Armstrong, RA Avant, CM Charchenko, ME Westerman, MJ Ziegelmann, TS Miest, LW Trost
Translational andrology and urology 2018
The new paradigm for androgenetic alopecia and plant-based folk remedies: 5α-reductase inhibition, reversal of secondary microinflammation and improving insulin resistance
NJ Sadgrove
Journal of Ethnopharmacology 2018
Molecular genetics and phenotype/genotype correlation of 5-α reductase deficiency in a highly consanguineous population
MM Alswailem, OS Alzahrani, L Alghofaili, E Qasem, M Almohanaa, A Alsagheir, BB Abbas, NA Attia, AA Shaikh, AS Alzahrani
Endocrine 2018
Seasonal expression of 5α-reductases and androgen receptor in the prostate gland of the wild ground squirrel ( Spermophilus dauricus )
Y Zhang, Y Wang, C Huang, Y Wang, H Qi, Y Han, Z Yuan, Q Weng, H Zhang
Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 2018
Alopecia androgenetica der Frau
G Lutz
gynäkologie + geburtshilfe 2018
5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
J Wang, S Zhao, L Luo, E Li, X Li, ZG Zhao
International braz j urol 2018
Effects of the Korean Medicinal Herbs for Treatment of Benign Prostatic Hyperplasia Induced in Rat Models: A Review
I Bae, S Jung
The Journal of Internal Korean Medicine 2018
Drugs for benign prostatic hypertrophy.
Jiwrajka M, Yaxley W, Ranasinghe S, Perera M, Roberts MJ, Yaxley J
Australian Prescriber 2018
Androgenetic alopecia: a review
F Lolli, F Pallotti, A Rossi, MC Fortuna, G Caro, A Lenzi, A Sansone, F Lombardo
Endocrine 2017
Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers
CK Zhou, FZ Stanczyk, M Hafi, CC Veneroso, B Lynch, RT Falk, S Niwa, E Emanuel, YT Gao, GP Hemstreet, L Zolfghari, PR Carroll, MJ Manyak, IA Sesterhenn, PH Levine, AW Hsing, MB Cook
The Prostate 2017
Anti-proliferative activities of finasteride in benign prostate epithelial cells require stromal fibroblasts and c-Jun gene
K Wang, S Jin, D Fan, M Wang, N Xing, Y Niu, HK Bid
PloS one 2017
Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
T Kiguradze, WH Temps, PR Yarnold, J Cashy, RE Brannigan, B Nardone, G Micali, DP West, SM Belknap
PeerJ 2017
Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels
A Rył, I Rotter, A Grzywacz, I Małecka, K Skonieczna-Żydecka, K Grzesiak, M Słojewski, A Szylińska, O Sipak-Szmigiel, M Piasecka, K Walczakiewicz, M Laszczyńska
International journal of environmental research and public health 2017
Targeting phenotypic heterogeneity in benign prostatic hyperplasia
DW Strand, DN Costa, F Francis, WA Ricke, CG Roehrborn
Differentiation; research in biological diversity 2017
Association between SRD5A2 rs523349 and rs9282858 Polymorphisms and Risk of Benign Prostatic Hyperplasia: A Meta-Analysis
XT Zeng, XJ Su, S Li, H Weng, TZ Liu, XH Wang
Frontiers in physiology 2017
Sensitivity of doping biomarkers after administration of a single dose testosterone gel
J Mullen, A Börjesson, O Hopcraft, JJ Schulze, M Ericsson, A Rane, M Lehtihet, L Ekström
Drug Testing and Analysis 2017
Seasonal expression of P450c17 and 5α-reductase-2 in the scented gland of male muskrats ( Ondatra zibethicus )
W Han, W Xie, Y Zhang, F Zhang, H Zhang, Y Han, Z Yuan, Q Weng
General and Comparative Endocrinology 2017
Letter to the Editor: “Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss”
J Santmann
The Journal of clinical endocrinology and metabolism 2017
Finasteride-loaded biodegradable nanoparticles: Near-infrared quantification of plasma and prostate levels
OA Ahmed, UA Fahmy, AS Al-Ghamdi, BM Aljaeid, H Aldawsari, O Fahmy, HA Sarhan, MG Asri
J BIOACT COMPAT POL 2017
Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer
G Leone, M Tucci, C Buttigliero, C Zichi, D Pignataro, P Bironzo, F Vignani, GV Scagliotti, MD Maio
Endocrine Related Cancer 2017
Butylated hydroxyanisole alters rat 5α-reductase and 3α-hydroxysteroid dehydrogenase: Implications for influences of neurosteroidogenesis
J Guo, L Li, S Zhou, Y Su, X Li, J Sun, RS Ge
Neuroscience Letters 2017
Allopregnanolone levels and depressive symptoms during pregnancy in relation to single nucleotide polymorphisms in the allopregnanolone synthesis pathway
C Hellgren, E Comasco, A Skalkidou, I Sundström-Poromaa
Hormones and Behavior 2017
Molecular basis for prostate cancer racial disparities
Santosh K Singh, James W Lillard Jr, Rajesh Singh
Frontiers in bioscience : a journal and virtual library 2017
Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man
JM Hazlehurst, AI Oprescu, N Nikolaou, RD Guida, AE Grinbergs, NP Davies, RB Flintham, MJ Armstrong, AE Taylor, BA Hughes, J Yu, L Hodson, WB Dunn, JW Tomlinson
The Journal of clinical endocrinology and metabolism 2016
Endocrinology: Adult and Pediatric
M Gurnell, TJ Visser, P Beck-Peccoz, VK Chatterjee
Endocrinology: Adult and Pediatric 2016
Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
HM Choi, Y Jung, J Park, HL Kim, DH Youn, JW Kang, MY Jeong, JH Lee, WM Yang, SG Lee, KS Ahn, JY Um
Scientific Reports 2016
Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials
LW Trost, JP Mulhall
Journal of Sexual Medicine 2016
The metabolic fate and receptor interaction of 16α-hydroxyprogesterone and its 5α-reduced metabolite, 16α-hydroxy-dihydroprogesterone
D Rooyen, T Toit, RL Toit, D Africander, P Swart, AC Swart
Molecular and Cellular Endocrinology 2016
Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia
GS Choi, JH Kim, SY Oh, JM Park, JS Hong, YS Lee, WS Lee
Annals of Dermatology 2016
Androgens modulate gene expression and specific DNA methylation pattern of steroid 5α-reductases in the frog Silurana tropicalis
S Bissegger, VS Langlois
General and Comparative Endocrinology 2016
Endocrinology
C Napier, SH Pearce
Endocrinology 2016
Upper-body resistance exercise augments vastus lateralis androgen receptor–DNA binding and canonical Wnt/β-catenin signaling compared to lower-body resistance exercise in resistance-trained men without an acute increase in serum testosterone
M Spillane, N Schwarz, DS Willoughby
Steroids 2015
Progesterone-induced stimulation of mammary tumorigenesis is due to the progesterone metabolite, 5α-dihydroprogesterone (5αP) and can be suppressed by the 5α-reductase inhibitor, finasteride
JP Wiebe, MA Rivas, MF Mercogliano, PV Elizalde, R Schillaci
The Journal of Steroid Biochemistry and Molecular Biology 2015
Generation of comparative pharmacophoric model for steroidal 5α-reductase I and II inhibitors: A 3D-QSAR study on 6-azasteroids
S Thareja, T Rajpoot, SK Verma
Steroids 2015
Hamster SRD5A3 lacks steroid 5α-reductase activity in vitro
B Chávez, L Ramos, R García-Becerra, F Vilchis
Steroids 2015
5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia
CH Chou, CL Lin, MC Lin, FC Sung, CH Kao
Journal of Endocrinological Investigation 2015
Human sperm molecular anatomy: the enzyme 5α-reductase (SRD5A) is present in the sperm and may be involved in the varicocele-related infertility
S Aquila, D Montanaro, C Guido, M Santoro, I Perrotta, S Gervasi, FD Amicis, M Lanzino
Histochemistry and Cell Biology 2015
Phenotype and molecular characteristics in 45 Chinese children with 5α-reductase type 2 deficiency from South China
J Cheng, R Lin, W Zhang, G Liu, H Sheng, X Li, Z Zhou, X Mao, L Liu
Clinical Endocrinology 2015
Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteers
MJ Fossler, DA Collins, H Ino, N Sarai, R Ravindranath, CL Bowen, O Burns
Journal of Drug Assessment 2015
Setting reference values in trichology
A Rebora, M Guarrera, F Drago, A Rossi, MC Fortuna, R D'Ovidio, P Chieco, BM Piraccini, M Starace
International Journal of Dermatology 2015
Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study
D Robinson, H Garmo, P Stattin, K Michaëlsson, J Kim
PloS one 2015
Anti-proliferation effects of Cistanches salsa on the progression of benign prostatic hyperplasia
E Jeon, KS Chung, H An
Canadian Journal of Physiology and Pharmacology 2015
The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
AM Traish
Current Sexual Health Reports 2015
Nutraceuticals and Functional Foods in Human Health and Disease Prevention
S Lee, T Vance, O Chun
Nutraceuticals and Functional Foods in Human Health and Disease Prevention 2015
Clinical profile of 93 cases of 46, XY disorders of sexual development in a referral center
BC Mota, LM Oliveira, R Lago, P Brito, AK Canguçú-Campinho, U Barroso, MB Toralles
International braz j urol 2015
The intriguing role of fibroblasts and c-Jun in the chemo-preventive and therapeutic effect of finasteride on xenograft models of prostate cancer
YN Niu, K Wang, S Jin, DD Fan, MS Wang, NZ Xing, SJ Xia
Asian Journal of Andrology 2015
Seasonal variation of urinary microRNA expression in male goats (Capra hircus) as assessed by next generation sequencing
KM Longpre, NS Kinstlinger, EA Mead, Y Wang, AP Thekkumthala, KA Carreno, A Hot, JM Keefer, L Tully, LS Katz, AZ Pietrzykowski
General and Comparative Endocrinology 2014
Genetic Steroid Disorders
DE Reichman, Z Rosenwaks
Genetic Steroid Disorders 2014
5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann’s area 9 (BA9) of depressed patients
RC Agis-Balboa, A Guidotti, G Pinna
Psychopharmacology 2014
Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues: Finasteride Alters AR Expression
TM Bauman, PD Sehgal, KA Johnson, T Pier, RC Bruskewitz, WA Ricke, W Huang
The Prostate 2014
Differential expression of 5-alpha reductase isozymes in the prostate and its clinical implications
K Wang, DD Fan, S Jin, NZ Xing, YN Niu
Asian Journal of Andrology 2014
Androgens and prostate disease
LA Cooper, ST Page
Asian Journal of Andrology 2014
Cellular Endocrinology in Health and Disease
AA Bremer, WL Miller
Cellular Endocrinology in Health and Disease 2014
Relative adrenal insufficiency in mice deficient in 5α-reductase 1
DE Livingstone, EM di Rollo, C Yang, LE Codrington, JA Mathews, M Kara, KA Hughes, CJ Kenyon, BR Walker, R Andrew
Journal of Endocrinology 2014
Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
C Welliver, M Butcher, Y Potini, KT McVary
Current Urology Reports 2014
Gender Differences in Multiple Sclerosis: Induction of Estrogen Signaling in Male and Progesterone Signaling in Female Lesions
S Luchetti, CG van Eden, K Schuurman, ME van Strien, DF Swaab, I Huitinga
Journal of Neuropathology and Experimental Neurology 2014
GENDER-SPECIFIC ASSOCIATION OF VARIANTS IN THE AKR1C1 GENE WITH DIMENSIONAL ANXIETY IN PATIENTS WITH PANIC DISORDER: ADDITIONAL EVIDENCE FOR THE IMPORTANCE OF NEUROSTEROIDS IN ANXIETY?: Research Article: Association of AKR1C1 Variants with Anxiety
C Quast, A Reif, T Brückl, H Pfister, H Weber, M Mattheisen, S Cichon, T Lang, A Hamm, L Fehm, A Ströhle, V Arolt, K Domschke, T Kircher, HU Wittchen, P Pauli, AL Gerlach, GW Alpers, J Deckert, R Rupprecht, EB Binder, A Erhardt
Depression and Anxiety 2014
Phenotypic and molecular characteristics in eleven Chinese patients with 5α-reductase Type 2 deficiency
H Zhu, W Liu, B Han, M Fan, S Zhao, H Wang, Y Lu, C Pan, F Chen, M Chen, H Song, K Cheng, J Qiao
Clinical Endocrinology 2014
Pathways and genes involved in steroid hormone metabolism in male pigs: A review and update
A Robic, T Faraut, A Prunier
The Journal of Steroid Biochemistry and Molecular Biology 2014
Mechanisms of crosstalk between endocrine systems: Regulation of sex steroid hormone synthesis and action by thyroid hormones
P Duarte-Guterman, L Navarro-Martín, VL Trudeau
General and Comparative Endocrinology 2014
A population-based nested case-control study: the use of 5-alpha-reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia
WL Lin, YW Hsieh, CL Lin, FC Sung, CH Wu, CH Kao
Clinical Endocrinology 2014
5α-Reductase Type 1 Deficiency or Inhibition Predisposes to Insulin Resistance, Hepatic Steatosis, and Liver Fibrosis in Rodents
DE Livingstone, P Barat, EM di Rollo, GA Rees, BA Weldin, EA Rog-Zielinska, DP MacFarlane, BR Walker, R Andrew
Diabetes 2014
Steroidal pyrazolines and pyrazoles as potential 5α-reductase inhibitors: Synthesis and biological evaluation
AH Banday, SA Shameem, S Jeelani
Steroids 2014
Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis
SE Borst, JJ Shuster, B Zou, F Ye, H Jia, A Wokhlu, JF Yarrow
BMC Medicine 2014
The Impact of Exogenic Testosterone and Nortestosterone-Decanoate Toxicological Evaluation Using a Rat Model
RT Cristina, F Hanganu, E Dumitrescu, F Muselin, M Butnariu, A Constantin, V Chiurciu, B He
PloS one 2014
Effects of Unripe Black Raspberry Extracts on Prostate Cancer Cell Line and Rat Model of Benign Prostatic Hyperplasia
SJ Lee, HR Choi, JH Lee, JW Kwon, HK Lee, JT Jeong, TB Lee
Journal of the Korean Society of Food Science and Nutrition 2014
Expression levels of mRNA for neurosteroidogenic enzymes 17β-HSD, 5α-reductase, 3α-HSD and cytochrome P450 aromatase in the fetal wild type and SF-1 knockout mouse brain
T Spanic, T Fabjan, G Majdic
Endocrine Research 2014
Reference Module in Biomedical Sciences
DL Sackett, RB Haynes
2014
α-spinasterol from Melandrium firmum attenuates benign prostatic hyperplasia in a rat model
MY Lee, IS Shin, H Kyoung, CS Seo, JK Son, HK Shin
Molecular medicine reports 2014
Pathogenesis and Treatment of Acne and Rosacea
CC Zouboulis, AD Katsambas, AM Kligman
2014
Targeting cancer using cholesterol conjugates
AA Radwan, FK Alanazi
Saudi Pharmaceutical Journal 2013
Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer
FZ Stanczyk, CG Azen, MC Pike
The Journal of Steroid Biochemistry and Molecular Biology 2013
Of marsupials and men: “Backdoor” dihydrotestosterone synthesis in male sexual differentiation
A Biason-Lauber, WL Miller, AV Pandey, CE Flück
Molecular and Cellular Endocrinology 2013
Side Effects of 5-Alpha Reductase Inhibitors: A Comprehensive Review: 5ARI Side Effects
L Trost, TR Saitz, WJ Hellstrom
Sexual Medicine Reviews 2013
Inhibition of dehydroepiandosterone sulfate action in androgen-sensitive tissues by EM-1913, an inhibitor of steroid sulfatase
J Roy, J Lefebvre, R Maltais, D Poirier
Molecular and Cellular Endocrinology 2013
21-Hydroxylase deficiency in the neonate – Trends in steroid anabolism and catabolism during the first weeks of life
S Christakoudi, DA Cowan, G Christakudis, NF Taylor
The Journal of Steroid Biochemistry and Molecular Biology 2013
Metabolic considerations of drugs in the treatment of allergic diseases
E García-Martín, G Canto, JA Agúndez
Expert Opinion on Drug Metabolism & Toxicology 2013
Hair loss and herbs for treatment
N Lourith, M Kanlayavattanakul
Journal of Cosmetic Dermatology 2013
Sex dependent influence of a functional polymorphism in steroid 5-α-reductase type 2 (SRD5A2) on post-traumatic stress symptoms
CF Gillespie, LM Almli, AK Smith, B Bradley, K Kerley, DF Crain, KB Mercer, T Weiss, J Phifer, Y Tang, JF Cubells, EB Binder, KN Conneely, KJ Ressler
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2013
Metabolism of BYZX in Human Liver Microsomes and Cytosol: Identification of the Metabolites and Metabolic Pathways of BYZX
L Yu, Y Jiang, L Wang, R Sheng, Y Hu, S Zeng, C Holscher
PloS one 2013
Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes
J Li, E Mercer, X Gou, YJ Lu
American journal of cancer research 2013
Androgens and prostate disease
LA Cooper, ST Page
Asian Journal of Andrology 2013
Bisphenol A Modifies the Regulation Exerted by Testosterone on 5 α -Reductase Isozymes in Ventral Prostate of Adult Rats
P Sánchez, B Castro, JM Torres, A Olmo, RG Moral, E Ortega
BioMed Research International 2013
Dihydrotestosterone is elevated following sprint exercise in healthy young men
AA Smith, R Toone, O Peacock, S Drawer, KA Stokes, CJ Cook
Journal of applied physiology 2013
Clinical biochemistry of dihydrotestosterone
PM Marchetti, JH Barth
Annals of Clinical Biochemistry 2013
5-alpha-reductase type I (SRD5A1) is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosis
FG Kapp, A Sommer, T Kiefer, G Dölken, B Haendler
Cancer Cell International 2012
Testosterone and Vascular Function in Aging
RA Lopes, KB Neves, FS Carneiro, RC Tostes
Frontiers in physiology 2012
Basal and Regulatory Promoter Studies of the AKR1C3 Gene in Relation to Prostate Cancer
JJ Schulze, H Karypidis, L Ekström
Frontiers in pharmacology 2012
Genome-Wide Association Study of d-Amphetamine Response in Healthy Volunteers Identifies Putative Associations, Including Cadherin 13 (CDH13)
AB Hart, BE Engelhardt, MC Wardle, G Sokoloff, M Stephens, H Wit, AA Palmer
PloS one 2012
Dutasteride monotherapy in men with serologic relapse following radical therapy for adenocarcinoma of the prostate: A pilot study
M Perrotti, R Jain, LM Abriel, TE Baroni, AB Corbett, SA Tenenbaum
Urologic Oncology Seminars and Original Investigations 2012
Expression of 5α-reductase in apocrine carcinoma of the breast and its correlation with clinicopathological aggressiveness : 5α-Reductase in apocrine carcinoma of the breast
S Kasashima, A Kawashima, S Ozaki, Y Nakanuma
Histopathology 2012
Promotion of Hair Growth by Rosmarinus officinalis Leaf Extract : HAIR GROWTH EFFECT OF Rosmarinus officinalis LEAF
K Murata, K Noguchi, M Kondo, M Onishi, N Watanabe, K Okamura, H Matsuda
Phytotherapy Research 2012
Campbell-Walsh Urology
I Singh, JW Strandhoy, DG Assimos
Campbell-Walsh Urology 2012
Cochrane Database of Systematic Reviews: Protocols
JJ Ho, AS Adnan, Z Darus, NZ Ismail, HV Rostenberghe, JJ Ho
Cochrane Database of Systematic Reviews: Protocols 2012
Association of V89L SRD5A2 polymorphism with craving and serum leptin levels in male alcohol addicts
B Lenz, E Schöpp, CP Müller, S Bleich, T Hillemacher, J Kornhuber
Psychopharmacology 2012
Regional distribution of 5α-reductase type 2 in the adult rat brain: An immunohistochemical analysis
MP Castelli, A Casti, A Casu, R Frau, M Bortolato, S Spiga, MG Ennas
Psychoneuroendocrinology 2012
Inhibiteurs des 5 alpha-réductases et cancer de la prostate : une mise au point du Comité de cancérologie de l’Association française d’urologie
P Eschwège, N Gaschignard, G Ploussard, M Peyromaure, C Bastide, L Cormier, P Mongiat-Artus, F Rozet, G Fromont, C Hennequin, R Renard-Penna, P Beuzeboc, P Richaud, M Soulié, L Salomon
Progrès en Urologie 2012
The activities of 5α-reductase and 17,20-lyase determine the direction through androgen synthesis pathways in patients with 21-hydroxylase deficiency
C Kamrath, MF Hartmann, T Remer, SA Wudy
Steroids 2012
The Basic Science of Hair Biology
T Breitkopf, G Leung, M Yu, E Wang, KJ McElwee
Dermatologic Clinics 2012
5α-Reductases in Human Physiology: An Unfolding Story
AM Traish
Endocrine Practice 2012
Adipocyte biology in polycystic ovary syndrome
TM Barber, S Franks
Molecular and Cellular Endocrinology 2012
Women with acute intermittent porphyria have a defect in 5α-steroid production during the menstrual cycle: Effects of porphyria on the menstrual cycle
E Innala, T Bäckström, IS Poromaa, C Andersson, M Bixo
Acta Obstetricia et Gynecologica Scandinavica 2012
Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
S Gur, PJ Kadowitz, WJ Hellstrom
Expert Opinion on Drug Safety 2012
Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride
AR Kristal, C Till, CM Tangen, PJ Goodman, ML Neuhouser, FZ Stanczyk, LW Chu, SK Patel, IM Thompson, JK Reichardt, A Hoque, EA Platz, WD Figg, AV Bokhoven, SM Lippman, AW Hsing
Cancer epidemiology, biomarkers & prevention 2012
The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
F Azzouni, A Godoy, Y Li, J Mohler
Advances in Urology 2012
Variants in the SRD5A2 gene are associated with quality of semen
D Zhao, W Wu, B Xu, X Niu, H Cui, YI ZHANG, Z Wang, X Wang
Molecular medicine reports 2012
Increased Activation of the Alternative “Backdoor” Pathway in Patients with 21-Hydroxylase Deficiency: Evidence from Urinary Steroid Hormone Analysis
C Kamrath, Z Hochberg, MF Hartmann, T Remer, SA Wudy
The Journal of clinical endocrinology and metabolism 2012
Intracrine and Myotrophic Roles of 5α-Reductase and Androgens: A Review
JF Yarrow, SC Mccoy, SE Borst
Medicine and Science in Sports and Exercise 2012
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
WL Miller, RJ Auchus
Endocrine reviews 2011
Potential prostate cancer drug target: Bioactivation of androstanediol by conversion to dihydrotestosterone
JL Mohler, MA Titus, EM Wilson
Clinical cancer research 2011
Estrogen and androgen signaling in the pathogenesis of BPH
CK Ho, FK Habib
Nature Reviews Urology 2011
Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis
S Luchetti, I Huitinga, DF Swaab
Neuroscience 2011
Synthesis and bioactivity of new Finasteride conjugate
Z Shuang, W Jiazhen, Y Lijuan, L Zhuo, Y Dahai, L Jinfeng, Y Jing, L Yongtao, W En-si, F Xuexun
Bioorganic & Medicinal Chemistry Letters 2011
Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism
K Unluhizarci, G Kaltsas, F Kelestimur
European Journal of Clinical Investigation 2011
Neurosteroid biosynthetic pathways changes in prefrontal cortex in Alzheimer's disease
S Luchetti, K Bossers, SV de Bilt, V Agrapart, RR Morales, GV Frajese, DF Swaab
Neurobiology of Aging 2011
The Effects of 5α-Reductase Inhibition on Benign Prostatic Hyperplasia Treated by Photoselective Vaporization Prostatectomy with the 120 Watt GreenLight HPS Laser System
KH Strom, X Gu, M Spaliviero, C Wong
Journal of the American College of Surgeons 2011
The Critical Role of Androgens in Prostate Development
JD Wilson
Endocrinology & Metabolism Clinics of North America 2011
Molecular biology of androgen insensitivity
J Jääskeläinen
Molecular and Cellular Endocrinology 2011
Annual Reports in Medicinal Chemistry
JJ Liu, TW Lee
Annual Reports in Medicinal Chemistry Volume 46 2011
A randomised, placebo-controlled trial of dutasteride in spinal and bulbar muscular atrophy
LE Fernández-Rhodes, AD Kokkinis, MJ White, CA Watts, S Auh, NO Jeffries, JA Shrader, TJ Lehky, L Li, JE Ryder, EW Levy, BI Solomon, MO Harris-Love, AL Pean, AB Schindler, C Chen, NA di Prospero, KH Fischbeck
Lancet neurology 2011
Hair Biology and Care Product Ingredients from Marine Organisms
SK Kim, SS Bak
Marine Cosmeceuticals Trends and Prospects 2011
5 -Reduced glucocorticoids: a story of natural selection
M Nixon, R Upreti, R Andrew
Journal of Endocrinology 2011
Williams Textbook of Endocrinology
DW Cooke, SA Divall, S Radovick
Williams Textbook of Endocrinology 2011
Increase in formalin-induced tonic pain by 5alpha-reductase and aromatase inhibition in female rats
M Moradi-Azani, A Ahmadiani, H Amini
Pharmacology Biochemistry and Behavior 2011
Dihydrotestosterone stimulates amino acid uptake and the expression of LAT2 in mouse skeletal muscle fibres through an ERK1/2-dependent mechanism: Amino acid uptake in mouse skeletal muscle fibres
MM Hamdi, G Mutungi
The Journal of Physiology 2011
Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA
AW Rafi, RM Katz
ISRN Dermatology 2011
Synthesis and 5α-Reductase Inhibitory Activity of C21 Steroids Having 1,4-diene or 4,6-diene 20-ones and 4-Azasteroid 20-Oximes
S Kim, Y Kim, E Ma
Molecules (Basel, Switzerland) 2011
Handbook of Growth and Growth Monitoring in Health and Disease
VR Preedy
2011
Hormonal and Genetic Basis of Sexual Differentiation Disorders and Hot Topics in Endocrinology: Proceedings of the 2nd World Conference
MI New, JL Simpson
2011
Hormonal and Genetic Basis of Sexual Differentiation Disorders and Hot Topics in Endocrinology: Proceedings of the 2nd World Conference
MI New, JL Simpson
2011
Hormonal and Genetic Basis of Sexual Differentiation Disorders and Hot Topics in Endocrinology: Proceedings of the 2nd World Conference
MI New, JL Simpson
2011
Hormonal and Genetic Basis of Sexual Differentiation Disorders and Hot Topics in Endocrinology: Proceedings of the 2nd World Conference
MI New, JL Simpson
2011
Potential Prostate Cancer Drug Target: Bioactivation of Androstanediol by Conversion to Dihydrotestosterone: Figure 1
JL Mohler, MA Titus, EM Wilson
Clinical cancer research 2011
46,XY DSD due to impaired androgen production
BB Mendonca, EM Costa, A Belgorosky, MA Rivarola, S Domenice
Best Practice & Research Clinical Endocrinology & Metabolism 2010
Series in Cosmetic and Laser Therapy
NE Rogers, MR Avram
Hair Transplantation 2010
Biology and natural history of prostate cancer and the role of chemoprevention
MT Rosenberg, M Froehner, D Albala, MM Miner
International Journal of Clinical Practice 2010
Determination of rat 5α-reductase type 1 isozyme activity and its inhibition by novel steroidal oxazolines
M Szécsi, D Ondré, I Tóth, S Magony, J Wölfling, G Schneider, J Julesz
Acta Biologica Hungarica 2010
Androgen receptor and 5α-reductase immunohistochemical profiles in extramammary Paget disease
S Kasashima, S Ozaki, A Kawashima, Y Zen, T Moriya, M Inoue
British Journal of Dermatology 2010
5αDH-DOC (5α-dihydro-deoxycorticosterone) activates androgen receptor in castration-resistant prostate cancer
M Uemura, S Honma, S Chung, R Takata, M Furihata, K Nishimura, N Nonomura, Y Nasu, T Miki, T Shuin, T Fujioka, A Okuyama, Y Nakamura, H Nakagawa
Cancer Science 2010
Cloning and differential expression of steroid 5α-reductase type 1 (Srd5a1) and type 2 (Srd5a2) from the Harderian glands of hamsters
L Ramos, B Chávez, F Vilchis
General and Comparative Endocrinology 2010
Pathogenesis of Prostate Cancer
CY Yoon, SS Byun
Journal of Korean Medical Association 2010
Correlation between circulatory, local prostatic, and intra-prostatic androgen levels
M Olsson, L Ekström, C Guillemette, A Belanger, A Rane, O Gustafsson
The Prostate 2010
Establishment of a Novel Model for Studying the Effects of Extracts of Chinese Herb Medicine on Human Type II 5α-Reductase in Vitro
X WANG, J LIAO, D YIN, F ZHAN, S DAI, G XIE, X SANG
YAKUGAKU ZASSHI 2010
Undervirilization in XY newborns may hide a 5α-reductase deficiency: report of three new SRD5A2 gene mutations
L Maimoun, P Philibert, B Cammas, F Audran, C Pienkowski, F Kurtz, C Heinrich, M Cartigny, C Sultan
International Journal of Andrology 2010
Evolution of steroid-5α-reductases and comparison of their function with 5β-reductase
VS Langlois, D Zhang, GM Cooke, VL Trudeau
General and Comparative Endocrinology 2010
Self-organizing molecular field analysis on pregnane derivatives as human steroidal 5α-reductase inhibitors
S Aggarwal, S Thareja, TR Bhardwaj, M Kumar
Steroids 2010
Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study
HC Eun, OS Kwon, JH Yeon, HS Shin, BY Kim, BI Ro, HK Cho, WY Sim, BL Lew, WS Lee, HY Park, SP Hong, JH Ji
Journal of the American Academy of Dermatology 2010
Vitamins & Hormones
KJ Hare, FK Knop
Vitamins & Hormones 2010
Benign Prostatic Hyperplasia
DR Paolone
Clinics in Geriatric Medicine 2010
Dihydrotestosterone activates the MAPK pathway and modulates maximum isometric force through the EGF receptor in isolated intact mouse skeletal muscle fibres: Acute effects of DHT in isolated intact mouse skeletal muscle fibres
MM Hamdi, G Mutungi
The Journal of Physiology 2010
Clinical, hormonal, and molecular-genetic characteristics of three cases of 46XY disorder of sex development caused by type II 5-alpha reductase deficiency
AA Kolodkina, ME Karmanov, NI Kalinchenko, AN Nizhnik, MA Nokel', AK Faĭzulin, AN Tiul'pakov
Problems of Endocrinology 2010
3D-QSAR studies on unsaturated 4-azasteroids as human 5α-reductase inhibitors: A self organizing molecular field analysis approach
S Aggarwal, S Thareja, TR Bhardwaj, M Kumar
European Journal of Medicinal Chemistry 2010
Expanding the Use of Fluorogenic Enzyme Reporter Substrates to Imaging Metabolic Flux Changes: the Activity Measurement of 5α-Steroid Reductase in Intact Mammalian Cells
PC Rodriguez, DJ Yee, D Sames
ACS chemical biology 2010
Drug Management of Prostate Cancer
WD Figg, CH Chau, EJ Small
2010
Limb Muscles Are Androgen Targets in an Acrobatic Tropical Bird
NY Feng, A Katz, LB Day, J Barske, BA Schlinger
Endocrinology 2010
5αDH‐DOC (5α‐dihydro‐deoxycorticosterone) activates androgen receptor in castration‐resistant prostate cancer
Uemura M, Honma S, Chung S, Takata R, Furihata M, Nishimura K, Nonomura N, Nasu Y, Miki T, Shuin T, Fujioka T, Okuyama A, Nakamura Y, Nakagawa H
Cancer Science 2010
Doping in Sports
D Thieme, P Hemmersbach
2009
Doping in Sports
D Thieme, P Hemmersbach
2009
Doping in Sports
D Thieme, P Hemmersbach
2009
Basic and Clinical Dermatology
N Muizzuddin, D Maes, P Giacomoni
Skin Moisturization 2009
Yen & Jaffe's Reproductive Endocrinology
RA Lobo
Yen & Jaffe's Reproductive Endocrinology 2009
Changes in human placental 5α-reductase isoenzyme expression with advancing gestation: effects of fetal sex and glucocorticoid exposure
TT Vu, JJ Hirst, M Stark, IM Wright, HK Palliser, N Hodyl, VL Clifton
Reproduction, Fertility and Development 2009
5α-Reductase Isozymes and Androgen Actions in the Prostate
YS Zhu, JL Imperato-McGinley
Annals of the New York Academy of Sciences 2009
Radical prostatectomy: Influence on serum and urinary androgen levels
M Olsson, L Ekström, J Schulze, A Kjellman, O Akre, A Rane, O Gustafsson
The Prostate 2009
Neurosteroid biosynthesis: Enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides
JL Rego, JY Seong, D Burel, J Leprince, V Luu-The, K Tsutsui, MC Tonon, G Pelletier, H Vaudry
Frontiers in Neuroendocrinology 2009
Overexpression of 5α-reductase type 1 increases sensitivity of prostate cancer cells to low concentrations of testosterone
LN Thomas, RC Douglas, RS Rittmaster, CK Too
The Prostate 2009
Genetic Analysis of the SRD5A2 Gene in Indian Patients with 5α-Reductase Deficiency
R Sahu, R Boddula, P Sharma, V Bhatia, R Greaves, S Rao, M Desai, A Wakhlu, S Phadke, M Shukla, P Dabadghao, RN Mehrotra, E Bhatia
Journal of Pediatric Endocrinology and Metabolism 2009
Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase
AN Vis, FH Schröder
BJU International 2009
Serum LH correlates highly with intratesticular steroid levels in normal men
MY Roth, K Lin, JK Amory, AM Matsumoto, BD Anawalt, CN Snyder, TF Kalhorn, WJ Bremner, ST Page
Journal of andrology 2009
Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer
ED Crawford
Urology 2009
Yen & Jaffe's Reproductive Endocrinology
SF Thung, ER Norwitz
Yen & Jaffe's Reproductive Endocrinology 2009
Hormones, Brain and Behavior
J Bernal
Hormones, Brain and Behavior 2009
Genetic variation in androgen disposition: implications in clinical medicine including testosterone abuse
JJ Schulze, A Rane, L Ekström
Expert Opinion on Drug Metabolism & Toxicology 2009
Cosmetics Applications of Laser & Light-Based Systems
VA Randall, NV Botchkareva
Cosmetics Applications of Laser & Light-Based Systems 2009
Synthesis of Pregnane Derivatives, Their Cytotoxicity on LNCap and PC-3 Cells, and Screening on 5α-Reductase Inhibitory Activity
S Kim, E Ma
Molecules (Basel, Switzerland) 2009
Androgen Action in Prostate Cancer
J Mohler, D Tindall
2009
Prostate Cancer Screening
DP Ankerst, CM Tangen, IM Thompson
2009
Androgen synthesis in adrenarche
WL Miller
Reviews in Endocrine and Metabolic Disorders 2008
Pharmacology of anabolic steroids
AT Kicman
British Journal of Pharmacology 2008
The Effect of 5α-Reductase Inhibition With Dutasteride and Finasteride on Bone Mineral Density, Serum Lipoproteins, Hemoglobin, Prostate Specific Antigen and Sexual Function in Healthy Young Men
JK Amory, BD Anawalt, AM Matsumoto, ST Page, WJ Bremner, C Wang, RS Swerdloff, RV Clark
The Journal of Urology 2008
Molecular diagnosis of 5α-reductase-2 gene mutation in two Indian families with male pseudohermaphroditism
M Eunice, P Philibert, B Kulshreshtha, F Audran, F Paris, ML Khurana, PE Pulikkanath, K Kucheria, C Sultan, AC Ammini
Asian Journal of Andrology 2008
Gender Identity of Children and Young Adults with 5α-Reductase Deficiency
EP Praveen, AK Desai, ML Khurana, J Philip, M Eunice, R Khadgawat, B Kulshreshtha, K Kucheria, DK Gupta, A Seith, AC Ammini
Journal of Pediatric Endocrinology and Metabolism 2008
Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer
K Das, PY Cheah, PL Lim, YB Zain, FC Stephanie, Y Zhao, C Cheng, W Lau
Cancer Letters 2008
Androgen deprivation therapy for precancerous lesions of the prostate
D Hull, DG Bostwick
Best Practice & Research Clinical Endocrinology & Metabolism 2008
5-Alpha Reductase Inhibitors and Erectile Dysfunction: The Connection
F Erdemir, A Harbin, WJ Hellstrom
Journal of Sexual Medicine 2008
Type 1 and Type 2 5α-Reductase Expression in the Development and Progression of Prostate Cancer
LN Thomas, RC Douglas, CB Lazier, CK Too, RS Rittmaster, DJ Tindall
European Urology 2008
Androgen biosynthetic pathways in the human prostate
V Luu-The, A Bélanger, F Labrie
Best Practice & Research Clinical Endocrinology & Metabolism 2008
A potential paradox in prostate adenocarcinoma progression: Oestrogen as the initiating driver
PB Singh, SS Matanhelia, FL Martin
European Journal of Cancer 2008
5-alpha-reductase and the development of the human prostate
C Radmayr, A Lunacek, C Schwentner, J Oswald, H Klocker, G Bartsch
Indian journal of urology : IJU : journal of the Urological Society of India 2008
The Adrenal Cortex and Its Disorders
WL Miller, JC Achermann, CE Flück
Pediatric Endocrinology 2008
Medical treatments for male and female pattern hair loss
NE Rogers, MR Avram
Journal of the American Academy of Dermatology 2008
Évolution de la cellule normale à la cellule cancéreuse prostatique hormonodépendante–hormono-indépendante
PM Martin, X Muracciole, C Berenguer, F Boudouresque, LH Ouafik
Médecine Nucléaire 2008
Polymorphisms of steroid 5- α- reductase type I (SRD5A1) gene are associated to peripheral arterial disease
SS Signorelli, V Barresi, N Musso, M Anzaldi, E Croce, V Fiore, DF Condorelli
Journal of Endocrinological Investigation 2008
The effect of finasteride on spermatogenesis of Mesocricetus auratus
DJ Vidigal, AL da Silva, LM da Fonseca, AC Vasconcelos, DF de Resende, FE Vidigal
Acta Cirurgica Brasileira 2008
Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle
K Sato, M Iemitsu, K Aizawa, R Ajisaka
American journal of physiology. Endocrinology and metabolism 2008
Hair Growth and Disorders
U Blume-Peytavi, A Tosti, RM Trüeb
2008
Dermatologic Manifestations of Polycystic Ovary Syndrome
AT Lee, LT Zane
American Journal of Clinical Dermatology 2007
Novel 5α-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer
M Uemura, K Tamura, S Chung, S Honma, A Okuyama, Y Nakamura, H Nakagawa
Cancer Science 2007
Finasteride to Evaluate the Efficacy of Dutasteride in the Management of Patients with Lower Urinary Tract Symptoms and Enlarged Prostate
IR Ravish, RB Nerli, SS Amarkhed
Systems Biology in Reproductive Medicine 2007
Oxytocin increases 5α-reductase activity of human prostate epithelial cells, but not stromal cells
SJ Assinder
The Prostate 2007
Medical treatment of benign prostatic hyperplasia
SS Connolly, JM Fitzpatrick
Postgraduate medical journal 2007
Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH)
AJ Cambio, CP Evans
Therapeutics and Clinical Risk Management 2007
Establishment of type II 5α-reductase over-expressing cell line as an inhibitor screening model
S Jang, Y Lee, SL Hwang, MH Lee, SJ Park, IH Lee, S Kang, SS Roh, YJ Seo, JK Park, JH Lee, CD Kim
The Journal of Steroid Biochemistry and Molecular Biology 2007
Fetal Distribution of 5α-Reductase 1 and 5α-Reductase 2, and Their Input on Human Prostate Development
A Lunacek, C Schwentner, J Oswald, H Fritsch, C Sergi, LN Thomas, RS Rittmaster, H Klocker, H Neuwirt, G Bartsch, C Radmayr
The Journal of Urology 2007
Effects of various pesticides on human 5α-reductase activity in prostate and LNCaP cells
S Lo, I King, A Alléra, D Klingmüller
Toxicology in Vitro 2007
Handbook of Neurochemistry and Molecular Neurobiology
VH Routh, JJ McArdle, NM Sanders, Z Song, R Wang
Handbook of Neurochemistry and Molecular Neurobiology 2007
Effect of finasteride 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testosterone
C Kohler, K Tschumi, C Bodmer, M Schneiter, M Birkhaeuser
Gynecological Endocrinology 2007
The Leydig Cell in Health and Disease
AH Payne, MP Hardy
2007
The Effect of 5α-Reductase Inhibition with Dutasteride and Finasteride on Semen Parameters and Serum Hormones in Healthy Men
JK Amory, C Wang, RS Swerdloff, BD Anawalt, AM Matsumoto, WJ Bremner, SE Walker, LJ Haberer, RV Clark
The Journal of clinical endocrinology and metabolism 2007
Androgen Excess Disorders in Women
R Azziz, JE Nestler, D Dewailly
2007
Uroonkologie
H Rübben
2007
Novel 5α‐steroid reductase (SRD5A3, type‐3) is overexpressed in hormone‐refractory prostate cancer
Uemura M, Tamura K, Chung S, Honma S, Okuyama A, Nakamura Y, Nakagawa H
Cancer Science 2007
Persistent intraprostatic androgen concentrations after medical castration in healthy men
ST Page, DW Lin, EA Mostaghel, DL Hess, LD True, JK Amory, PS Nelson, AM Matsumoto, WJ Bremner
The Journal of clinical endocrinology and metabolism 2006
Pharmacokinetics and Pharmacodynamics of Nonsteroidal Androgen Receptor Ligands
W Gao, J Kim, JT Dalton
Pharmaceutical Research 2006
Tissue-specific transcription profiles of sex steroid biosynthesis enzymes and the androgen receptor
U Hoppe, PM Holterhus, L Wünsch, D Jocham, T Drechsler, S Thiele, C Marschke, O Hiort
Journal of Molecular Medicine 2006
A New Look at the 5?-Reductase Inhibitor Finasteride
DA Finn, AS Beadles-Bohling, EH Beckley, MM Ford, KR Gililland, RE Gorin-Meyer, KM Wiren
CNS Drug Reviews 2006
Common genetic polymorphisms and prognosis of sporadic cancers: prostate cancer as a model
T Habuchi
Future Oncology 2006
Regulation of prostate 5α-reductase-2 gene expression and prostate weight by dietary fat and caloric intake in the rat
LQ Cai, J Imperato-McGinley, YS Zhu
The Prostate 2006
Prevention of Benign Prostatic Hyperplasia Disease
LS Marks, CG Roehrborn, GL Andriole
The Journal of Urology 2006
Finasteride as a chemopreventive agent in prostate cancer: impact of the PCPT on urologic practice
MA Goetzl, JM Holzbeierlein
Nature Clinical Practice Urology 2006
5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
VM Hayes, G Severi, EJ Padilla, HA Morris, WD Tilley, MC Southey, DR English, RL Sutherland, JL Hopper, P Boyle, GG Giles
International Journal of Cancer 2006
The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
K Davenport, P Abrams
Aging Health 2006
Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis
RC Agís-Balboa, G Pinna, A Zhubi, E Maloku, M Veldic, E Costa, A Guidotti
Proceedings of the National Academy of Sciences 2006
A Critical Analysis of Permixon™ in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement
C Maccagnano, A Salonia, A Briganti, P Teillac, C Schulman, F Montorsi, P Rigatti
European Urology Supplements 2006
5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond
G Andriole
European Urology Supplements 2006
Genetic Instabilities and Neurological Diseases
R Krahe, LL Bachinski, B Udd
Genetic Instabilities and Neurological Diseases 2006
Principles of Molecular Medicine
MS Runge, C Patterson
2006
PTSD
N Kato, M Kawata, RK Pitman
2006
Chemistry and Structural Biology of Androgen Receptor
W Gao, CE Bohl, JT Dalton
Chemical Reviews 2005
Androgenic correlates of genetic variation in the gene encoding 5α-reductase type 1
JA Ellis, S Panagiotopoulos, A Akdeniz, G Jerums, SB Harrap
Journal of Human Genetics 2005
Folia Pharmacologica Japonica
Y Ohsugi, N Tsuchimoto
Folia Pharmacologica Japonica 2005
Topography and function of androgen-metabolizing enzymes in the central nervous system
Y Tsuruo
Anatomical Science International 2005
Population Pharmacokinetic–Pharmacodynamic Modeling of TF-505 Using Extension of Indirect Response Model by Incorporating a Circadian Rhythm in Healthy Volunteers
Y Matsumoto, T Fujita, Y Ishida, M Shimizu, H Kakuo, K Yamashita, M Majima, Y Kumagai
Biological & Pharmaceutical Bulletin 2005
Dutasteride: a novel dual inhibitor of 5α-reductase for benign prostatic hyperplasia
B Djavan, S Milani, YK Fong
Expert Opinion on Pharmacotherapy 2005
Localization of 5α-reductase in the rat main olfactory bulb
E Kiyokage, K Toida, T Suzuki-Yamamoto, K Ishimura
The Journal of Comparative Neurology 2005
Sexual dimorphism of growth plate prehypertrophic and hypertrophic chondrocytes in response to testosterone requires metabolism to dihydrotestosterone (DHT) by steroid 5-alpha reductase type 1
P Raz, E Nasatzky, BD Boyan, A Ornoy, Z Schwartz
Journal of Cellular Biochemistry 2005
The 5α-Reductase Type II A49T and V89L High-Activity Allelic Variants are More Common in Men with Prostate Cancer Compared with the General Population
YL Giwercman, PA Abrahamsson, A Giwercman, V Gadaleanu, G Ahlgren
European Urology 2005
Molecular Basis of Steroid Action in the Prostate
YS Zhu
Cellscience 2005
5α-Reductase Isozymes in the Prostate
YS Zhu, GH Sun
Journal of medical sciences (Taipei, Taiwan) 2005
Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase
S Marihart, M Harik, B Djavan
Reviews in urology 2005
In vivo evidence for an increase in 5alpha-reductase activity in the rat central nervous system following morphine exposure
H Amini, A Ahmadiani
International Journal of Developmental Neuroscience 2005
International Review of Neurobiology
ZT Bloomgarden
International review of neurobiology 2005
Pediatric Endocrinology
PS Thornton
Pediatric Endocrinology 2005
Cloning and Characterization of the 5α-Reductase Type 2 Promoter in the Rat Epididymis1
S Seenundun, B Robaire
Biology of reproduction 2005
Prevention of Hormone-Related Cancers: Prostate Cancer
HL Parnes, IM Thompson, LG Ford
Journal of Clinical Oncology 2005
Deficiência de 5alfa-redutase tipo 2: experiências de Campinas (SP) e Salvador (BA)
C Hackel, LE de Oliveira, MB Toralles, D Nunes-Silva, MM Tonini, LF Ferraz, L Steinmetz, D Damiani, LC de Oliveira, AT Maciel-Guerra, EG Stuchi-Perez, G Guerra-Júnior
Arquivos brasileiros de endocrinologia e metabologia 2005
Chemoprevention using dutasteride: the REDUCE trial:
LG Gomella
Current Opinion in Urology 2005
5?-reductase in human embryonic kidney cell line HEK293: Evidence for type II enzyme expression and activity
BU Panter, J Jose, RW Hartmann
Molecular and Cellular Biochemistry 2005
Hormonal Carcinogenesis IV
JJ Li, SA Li, A Llombart-Bosch
2005
Oral Testosterone in Oil Plus Dutasteride in Men: A Pharmacokinetic Study
JK Amory, WJ Bremner
The Journal of clinical endocrinology and metabolism 2005
Cochrane Database of Systematic Reviews
L Hooper, C Bartlett, GD Smith, S Ebrahim, L Hooper
Cochrane Database of Systematic Reviews 2004
Rooster feathering, androgenic alopecia, and hormone-dependent tumor growth: What is in common?
JA Mayer, CM Chuong, R Widelitz
Differentiation 2004
Agents in development for prostate cancer prevention
WG Nelson
Expert Opinion on Investigational Drugs 2004
Patients with a large prostate show a higher prevalence of androgenetic alopecia
WC Chen, CC Yang, GY Chen, MC Wu, HM Sheu, TS Tzai
Archives of Dermatological Research 2004
Messenger RNA levels and enzyme activities of 5 alpha-reductase types 1 and 2 in human benign prostatic hyperplasia (BPH) tissue
T Shirakawa, H Okada, B Acharya, Z Zhang, N Hinata, Y Wada, T Uji, S Kamidono, A Gotoh
The Prostate 2004
Phase I and clinical pharmacology of a type I and II, 5-alpha-reductase inhibitor (LY320236) in prostate cancer: elevation of estradiol as possible mechanism of action
MA Eisenberger, M Laufer, NJ Vogelzang, O Sartor, D Thornton, BL Neubauer, V Sinibaldi, G Lieskovsky, MA Carducci, M Zahurak, D Raghavan
Urology 2004
Anomalies de la différenciation sexuelle
F Kuttenn, MF d'Acremont, I Mowszowicz
EMC - Endocrinologie - Nutrition 2004
Ketocazole as an adjunct to finasteride in the treatment of androgenetic alopecia in men
BS Perez
Medical Hypotheses 2004
Selective non-steroidal inhibitors of 5α-reductase type 1
EG Occhiato, A Guarna, G Danza, M Serio
The Journal of Steroid Biochemistry and Molecular Biology 2004
Medical Treatment of BPH: An Update on Results
RE Power, JM Fitzpatrick
EAU Update Series 2004
Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma
MJ Lewis, JP Wiebe, JG Heathcote
BMC Cancer 2004
Comparison of the Pharmacological Effects of a Novel Selective Androgen Receptor Modulator, the 5α-Reductase Inhibitor Finasteride, and the Antiandrogen Hydroxyflutamide in Intact Rats: New Approach for Benign Prostate Hyperplasia
W Gao, JD Kearbey, VA Nair, K Chung, AF Parlow, DD Miller, JT Dalton
Endocrinology 2004
A systemic type i 5 α-reductase inhibitor is ineffective in the treatment of acne vulgaris
J Leyden, W Bergfeld, L Drake, F Dunlap, MP Goldman, AB Gottlieb, MP Heffernan, JG Hickman, M Hordinsky, M Jarrett, S Kang, A Lucky, G Peck, T Phillips, M Rapaport, J Roberts, R Savin, ME Sawaya, A Shalita, J Shavin, JC Shaw, L Stein, D Stewart, J Strauss, J Swinehart, L Swinyer, D Thiboutot, K Washenik, G Weinstein, D Whiting, F Pappas, M Sanchez, L Terranella, J Waldstreicher
Journal of the American Academy of Dermatology 2004
Chemotherapeutic Prevention Studies of Prostate Cancer
B Djavan, A Zlotta, C Schulman, P Teillac, P IVERSEN, LB Gibod, G Bartsch, M Marberger
The Journal of Urology 2004
CHEMOPREVENTION OF PROSTATE CANCER IN MEN AT HIGH RISK: RATIONALE AND DESIGN OF THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL
G Andriole, D Bostwick, O Brawley, L Gomella, M Marberger, D Tindall, S Breed, M SOMERVILLE, R Rittmaster
The Journal of Urology 2004
Serum Androgen Bioactivity in Adolescence: A Longitudinal Study of Boys with Constitutional Delay of Puberty
T Raivio, L Dunkel, S Wickman, OA Jänne
The Journal of clinical endocrinology and metabolism 2004
Hypospadias and Genital Development
LS Baskin
2004
Regulation of 5α-Reductase Isoforms by Oxytocin in the Rat Ventral Prostate
SJ Assinder, C Johnson, K King, HD Nicholson
Endocrinology 2004
Chemopr�vention des Prostatakarzinoms
B Djavan, I Thompson, MS Michel, M Waldert, C Seitz
Der Urologe, Ausgabe A 2004
Genetic polymorphisms and prostate cancer risk
A Gsur, E Feik, S Madersbacher
World Journal of Urology 2004
Neurosteroid Biosynthesis in the Human Brain and Its Clinical Implications
B Stoffel-Wagner
Annals of the New York Academy of Sciences 2003
5 Alpha-reductase inhibitors: whatʼs new?
CL Foley, RS Kirby
Current Opinion in Urology 2003
Molecular epidemiology of hypospadias: Review of genetic and environmental risk factors
JM Manson, MC Carr
Birth Defects Research Part A: Clinical and Molecular Teratology 2003
Analysis of genetic polymorphisms of steroid 5α-reductase type 1 and 2 genes in Korean men with androgenetic alopecia
SJ Ha, JS Kim, JW Myung, HJ Lee, JW Kim
Journal of Dermatological Science 2003
Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients
L Rossi, M Leveri, C Gritti, AD Silvestri, C Zavaglia, L Sonzogni, L Silvestri, E Civardi, MU Mondelli, EM Silini
Journal of Hepatology 2003
5α-Reductase Type 1 Immunostaining is Enhanced in Some Prostate Cancers Compared With Benign Prostatic Hyperplasia Epithelium
L Thomas, R Douglas, J Vessey, R Gupta, D Fontaine, R Norman, I Thompson, D Troyer, R Rittmaster, C Lazier
The Journal of Urology 2003
Characterization and modulation of sex steroid metabolizing activity in normal human keratinocytes in primary culture and HaCaT cells
S Gingras, C Turgeon, N Brochu, P Soucy, F Labrie, J Simard
The Journal of Steroid Biochemistry and Molecular Biology 2003
Prostate Cancer
WG Nelson, AM de Marzo, WB Isaacs
New England Journal of Medicine 2003
Comparative pharmacophore development for inhibitors of human and rat 5-α-reductase
J Faragalla, J Bremner, D Brown, R Griffith, A Heaton
Journal of Molecular Graphics and Modelling 2003
Frontiers in Neuroscience: The Role of the GABA-A Receptor
S Mellon
Frontiers in neuroscience 2003
Testosterone replacement therapy in male hypogonadism
MM Byrne, E Nieschlag
Journal of Endocrinological Investigation 2003
Nuclear Receptors
B Belandia, MG Parker
Cell 2003
Activity and expression of progesterone metabolizing 5α-reductase, 20α-hydroxysteroid oxidoreductase and 3α(β)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells
JP Wiebe, MJ Lewis
BMC Cancer 2003
Androgen-Induced Prostate-Specific Antigen Gene Expression Is Mediated via Dihydrotestosterone in LNCaP Cells
YS Zhu, LQ Cai, X You, JJ Cordero, Y Huang, J Imperato-McGinley
Journal of andrology 2003
5α-Reductase Isoenzymes 1 and 2 in the Rat Testis During Postnatal Development1
J Killian, K Pratis, RJ Clifton, PG Stanton, DM Robertson, L O'Donnell
Biology of reproduction 2003
Development of a quantitative RT-PCR method to study 5?-reductase mRNA isozymes in rat prostate in different androgen status
JM Torres, E Ruiz, E Ortega
The Prostate 2003
Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: Implications for finasteride therapy of prostate carcinoma
J Luo, TA Dunn, CM Ewing, PC Walsh, WB Isaacs
The Prostate 2003
Androgens in Health and Disease
CJ Bagatell, WJ Bremner
2003
New Evidence of Similarity between Human and Plant Steroid Metabolism: 5α-Reductase Activity in Solanum malacoxylon
F Rosati, G Danza, A Guarna, N Cini, ML Racchi, M Serio
Endocrinology 2003
Estimating the Contribution of the Prostate to Blood Dihydrotestosterone
AW Toorians, S Kelleher, LJ Gooren, M Jimenez, DJ Handelsman
The Journal of clinical endocrinology and metabolism 2003
Semiquantitative RT-PCR method coupled to capillary electrophoresis to study 5alpha-reductase mRNA isozymes in rat ventral prostate in different androgen status
Jesus M Torres, José A Gómez-Capilla, Estrella Ruiz, Esperanza Ortega
Molecular and Cellular Biochemistry 2003
Stable maintenance of 5alpha-reductase activity in long-term subcultures of fibroblasts derived from the foreskin
K Nakae, M Tsuji, T Kuraoka, S Cho, GR Cunha, H Shima
International Journal of Urology 2002
Androgens and male physiology the syndrome of 5α-reductase-2 deficiency
J Imperato-McGinley, YS Zhu
Molecular and Cellular Endocrinology 2002
The genetics of male undermasculinization
SF Ahmed, IA Hughes
Clinical Endocrinology 2002
Advances in male contraception
BM Brady, RA Anderson
Expert Opinion on Investigational Drugs 2002
A novel homozygous disruptive mutation in the SRD5A2-gene in a partially virilized patient with 5alpha-reductase deficiency
O Hiort, SM Schutt, M Bals-Pratsch, PM Holterhus, C Marschke, D Struve
International Journal of Andrology 2002
Androgens and alopecia
KD Kaufman
Molecular and Cellular Endocrinology 2002
Hormonal treatment for male-pattern hair loss: implications for cancer of the prostate?
WR Anderson, NM Harris, SA Holmes
BJU International 2002
Pharmacokinetics and pharmacodynamics of TF-505, a novel nonsteroidal 5alpha-reductase inhibitor, in normal subjects treated with single or multiple doses
T Fujita, Y Matsumoto, T Kimura, S Yokota, M Sawada, M Majima, Y Ohtani, Y Kumagai
British Journal of Clinical Pharmacology 2002
Expression of androgen receptor and 5?-reductases in the human normal endometrium and its disorders
K Ito, T Suzuki, J Akahira, T Moriya, C Kaneko, H Utsunomiya, N Yaegashi, K Okamura, H Sasano
International Journal of Cancer 2002
Inhibition of type 1 and type 2 5α-reductase activity by free fatty acids, active ingredients of Permixon®
JP Raynaud, H Cousse, PM Martin
The Journal of Steroid Biochemistry and Molecular Biology 2002
Evidence that steroid 5α-reductase isozyme genes are differentially methylated in human lymphocytes
M Rodrı́guez-Dorantes, M Lizano-Soberón, I Camacho-Arroyo, R Calzada-León, S Morimoto, N Téllez-Ascencio, MA Cerbón
The Journal of Steroid Biochemistry and Molecular Biology 2002
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia
CG Roehrborn, P Boyle, JC Nickel, K Hoefner, G Andriole
Urology 2002
Nonsteroidal compounds designed to mimic potent steroid sulfatase inhibitors
LC Ciobanu, V Luu-The, D Poirier
The Journal of Steroid Biochemistry and Molecular Biology 2002
Structure–activity relationships for inhibition of human 5α-reductases by polyphenols
RA Hiipakka, HZ Zhang, W Dai, Q Dai, S Liao
Biochemical Pharmacology 2002
Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine–metabolic and ultrasonographic differences
L Falsetti, A Gambera, S Andrico, E Sartori
Gynecological Endocrinology 2002
Early growth, adult body size and prostate cancer risk
GG Giles, G Severi, DR English, MR McCredie, R MacInnis, P Boyle, JL Hopper
International Journal of Cancer 2002
Pediatric Gender Assignment
SA Zderic, DA Canning, MC Carr, HM Snyder
2002
Integration of Pharmaceutical Discovery and Development
RT Borchardt, RM Freidinger, TK Sawyer, PL Smith
2002
Male Contraception
RA Anderson, DT Baird
Endocrine reviews 2002
Androgens and Androgen Receptor
C Chang
2002
Expression of 5alpha-Reductases in Human Epithelial Ovarian Cancer: Its Correlation with Androgen Receptor Status
JI Akahira, T Suzuki, K Ito, RD Darnel, T Moriya, S Sato, N Yaegashi, K Okamura, H Sasano
Cancer Science 2001
Developmental aspects of androgen action
IA Hughes, HN Lim, H Martin, NP Mongan, L Dovey, SF Ahmed, JR Hawkins
Molecular and Cellular Endocrinology 2001
5α-Reductase Inhibitors in the Treatment of Androgenetic Alopecia
KD Kaufman
International Journal of Cosmetic Surgery and Aesthetic Dermatology 2001
The genetics of androgenetic alopecia
JA Ellis, SB Harrap
Clinics in Dermatology 2001
Androgenetic alopecia in men and women
RD Sinclair, RP Dawber
Clinics in Dermatology 2001
Down-regulation of intestinal scavenger receptor class B, type I (SR-BI) expression in rodents under conditions of deficient bile delivery to the intestine
PJ Voshol, M Schwarz, A Rigotti, M Krieger, AK Groen, F Kuipers
Biochemical Journal 2001
5α-reductase inhibitors: what role should they play?
SA Kaplan
Urology 2001
A novel class of inhibitors for steroid 5α-Reductase: synthesis and evaluation of umbelliferone derivatives
G Fan, W Mar, MK Park, EW Choi, K Kim, S Kim
Bioorganic & Medicinal Chemistry Letters 2001
Clinical application of 5α-reductase inhibitors
A Cilotti, G Danza, M Serio
Journal of Endocrinological Investigation 2001
Effect of estrogen replacement therapy on distribution of myocardial blood flow in female anesthetized rabbits
JR Rouleau, A Dagnault, D Simard, B Lavallée, A Bélanger, A Blouin, JG Kingma
American journal of physiology. Heart and circulatory physiology 2001
Linear Relationships between the Ligand Binding Energy and the Activation Energy of Time-dependent Inhibition of Steroid 5α-Reductase by Δ 1 -4-Azasteroids
G Tian, CD Haffner
The Journal of biological chemistry 2001
Regulation of Uterine 5α-Reductase Type 1 in Mice1
D Minjarez, V Konda, RA Word
Biology of reproduction 2001
Minireview: Sex Differentiation
IA Hughes
Endocrinology 2001
Phenotypic Variation in a Family with Partial Androgen Insensitivity Syndrome Explained by Differences in 5α Dihydrotestosterone Availability
AL Boehmer, AO Brinkmann, RM Nijman, MC Verleun-Mooijman, P de Ruiter, MF Niermeijer, SL Drop
The Journal of clinical endocrinology and metabolism 2001
Expression of 5α‐Reductases in Human Epithelial Ovarian Cancer: Its Correlation with Androgen Receptor Status
Akahira J, Suzuki T, Ito K, Darnel RD, Moriya T, Sato S, Yaegashi N, Okamura K, Sasano H
Japanese journal of cancer research : Gann 2001
Partial sequencing and tissue distribution of the canine isoforms of steroid 5?-Reductase type I and type II
PN Span, A Bokhoven, AG Smals, CG Sweep, JA Schalken
The Prostate 2000
Neurosteroids: Biosynthesis and Function of These Novel Neuromodulators
NA Compagnone, SH Mellon
Frontiers in Neuroendocrinology 2000
The effects of diet on circulating sex hormone levels in men
NE Allen, TJ Key
Nutrition Research Reviews 2000
Nishi Nihon Hifuka
E MORITA
Nishi Nihon Hifuka 2000
Regional Differences of Pheromone Production in the Sebaceous Glands of Castrated Goats Treated with Testosterone
Y WAKABAYASHI, E IWATA, T KIKUSUI, Y TAKEUCHI, Y MORI
Journal of Veterinary Medical Science 2000
Male pattern hair loss: prevention rather than regrowth
M Ramos-e-Silva
International Journal of Dermatology 2000
Evaluation of the Tubular and Interstitial Functions of the Testis in 46,XY Patients with Ambiguous Genitalia
EG Stuchi-Perez, C Lukas-Croisier, MD Castro, MT Baptista, MR Scolfaro, AP Marques-De-Faria, C Hackel
Journal of Pediatric Endocrinology and Metabolism 2000
SAW PALMETTO FOR THE TREATMENT OF MEN WITH LOWER URINARY TRACT SYMPTOMS
GS Gerber
The Journal of Urology 2000
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia
VH Price, JL Roberts, M Hordinsky, EA Olsen, R Savin, W Bergfeld, V Fiedler, A Lucky, DA Whiting, F Pappas, J Culbertson, P Kotey, A Meehan, J Waldstreicher
Journal of the American Academy of Dermatology 2000
Hair and Its Disorders: Biology, Pathology and Management
V Randall
Hair and Its Disorders: Biology, Pathology and Management 2000
Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5α-reductase
AM McNulty, JE Audia, KG Bemis, RL Goode, VP Rocco, BL Neubauer
The Journal of Steroid Biochemistry and Molecular Biology 2000
Hormônio anti-mülleriano: revisão e contribuição para a investigação das ambigüidades genitais
EG Perez, GG Júnior
Arquivos brasileiros de endocrinologia e metabologia 2000
Terapia della calvizie e dell’irsutismo con inibitori della 5α-riduttasi
A Cilotti, G Danza, M Serio
L'Endocrinologo 2000
Role of Hormones in Pilosebaceous Unit Development
D Deplewski, RL Rosenfield
Endocrine reviews 2000
Idiopathic Hirsutism*
R Azziz, E Carmina, ME Sawaya
Endocrine reviews 2000
Finasteride, a Type 2 5α-reductase inhibitor, in the treatment of men with androgenetic alopecia
KD Kaufman, RP Dawber
Expert Opinion on Investigational Drugs 1999
Improvement in androgenetic alopecia in 53-76-year-old men using oral finasteride
S Brenner, H Matz
International Journal of Dermatology 1999
SELECTIVITY OF FINASTERIDE AS AN IN VIVO INHIBITOR OF 5 alpha-REDUCTASE ISOZYME ENZYMATIC ACTIVITY IN THE HUMAN PROSTATE
PN Span, MC Voller, AG Smals, FG Sweep, JA Schalken, MR Feneley, RS Kirby
The Journal of Urology 1999
Comparison of finasteride and flutamide in the treatment of idiopathic hirsutism
L Falsetti, A Gambera
Fertility and Sterility 1999
Acquired scalp alopecia. Part II: A review
JR Sullivan, S Kossard
Australasian Journal of Dermatology 1999
New frameshift mutation in the 5?-reductase type 2 gene in a Brazilian patient with 5?-reductase deficiency
LF Ferraz, MT Baptista, AT Maciel-Guerra, GG J�nior, C Hackel
American Journal of Medical Genetics 1999
5?-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3
P Negri-Cesi, A Colciago, A Poletti, M Motta
The Prostate 1999
5 alpha-REDUCTASE TYPE 2 MUTATIONS ARE PRESENT IN SOME BOYS WITH ISOLATED HYPOSPADIAS
RI Silver, DW Russell
The Journal of Urology 1999
5 α-REDUCTASE TYPE 2 MUTATIONS ARE PRESENT IN SOME BOYS WITH ISOLATED HYPOSPADIAS
RI Silver, DW Russell
The Journal of Urology 1999
Racial differences in the androgen/androgen receptor pathway in prostate cancer
CA Pettaway
Journal of the National Medical Association 1999
Differences in steroid 5α-reductase iso-enzymes expression between normal and pathological human prostate tissue
C Iehlé, F Radvanyi, SG de Medina, LH Ouafik, H Gérard, D Chopin, JP Raynaud, PM Martin
The Journal of Steroid Biochemistry and Molecular Biology 1999
The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia
L Drake, M Hordinsky, V Fiedler, J Swinehart, WP Unger, PC Cotterill, DM Thiboutot, N Lowe, C Jacobson, D Whiting, S Stieglitz, SJ Kraus, EI Griffin, D Weiss, P Carrington, C Gencheff, GW Cole, DM Pariser, ES Epstein, W Tanaka, A Dallob, K Vandormael, L Geissler, J Waldsteicher
Journal of the American Academy of Dermatology 1999
Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss
JL Roberts, V Fiedler, J Imperato-McGinley, D Whiting, E Olsen, J Shupack, D Stough, R DeVillez, R Rietschel, R Savin, W Bergfeld, J Swinehart, T Funicella, M Hordinsky, N Lowe, I Katz, A Lucky, L Drake, VH Price, D Weiss, E Whitmore, L Millikan, S Muller, C Gencheff, P Carrington, B Binkowitz, P Kotey, W He, K Bruno, C Jacobsen, L Terranella, GJ Gormley, KD Kaufman
Journal of the American Academy of Dermatology 1999
G-protein-coupled, extracellular Ca(2+)-sensing receptor: a versatile regulator of diverse cellular functions
J Fox, MA Miller, GB Stroup, EF Nemeth, SC Miller
Vitamins and hormones 1999
ANDROGEN METABOLISM AS IT AFFECTS HAIR GROWTH IN ANDROGENETIC ALOPECIA
KD Kaufman
Dermatologic Clinics 1999
The Role of Androgens in Male Gender Role Behavior
JD Wilson
Endocrine reviews 1999
5α-Reductase Activity in Women with Polycystic Ovary Syndrome1
AJ Jakimiuk, SR Weitsman, DA Magoffin
The Journal of clinical endocrinology and metabolism 1999
Neurosteroids
EE Baulieu, P Robel, M Schumacher
1999
7α-Methyl-19-Nortestosterone Maintains Sexual Behavior and Mood in Hypogonadal Men*
RA Anderson, CW Martin, AW Kung, D Everington, TC Pun, KC Tan, J Bancroft, K Sundaram, AJ Moo-Young, DT Baird
The Journal of clinical endocrinology and metabolism 1999
Finasteride: A Review of its Use in Male Pattern Hair Loss
KJ McClellan, A Markham
Drugs 1999
Molecular medicine of steroid hormone biosynthesis
A Biason-Lauber
Molecular Aspects of Medicine 1998
Effects of long-term treatment withSerenoa repens (Permixon®) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia
FD Silverio, S Monti, A Sciarra, PA Varasano, C Martini, S Lanzara, G D'Eramo, SD Nicola, V Toscano
The Prostate 1998
Pharmacokinetics and pharmacodynamics of FK143, a nonsteroidal inhibitor of steroid 5α-reductase, in healthy volunteers
M Katashima, T Irino, F Shimojo, A Kawamura, H Kageyama, N Higashi, Y Miyao, Y Tokuma, T Hata, K Yamamoto, Y Sawada, T Iga
Clinical Pharmacology & Therapeutics 1998
5α-Reductase Isozymes in the Central Nervous System
A Poletti, A Coscarella, P Negri-Cesi, A Colciago, F Celotti, L Martini
Steroids 1998
Finasteride in the treatment of men with androgenetic alopecia
KD Kaufman, EA Olsen, D Whiting, R Savin, R DeVillez, W Bergfeld, VH Price, DV Neste, JL Roberts, M Hordinsky, J Shapiro, B Binkowitz, GJ Gormley
Journal of the American Academy of Dermatology 1998
Regional Distribution of 5α-Reductase Type 1 and Type 2 mRNA Along the Human Epididymis
MC Mahony, DJ Swanlund, M Billeter, KP Roberts, JL Pryor
Fertility and Sterility 1998
Genetic Analysis of Male Pattern Baldness and the 5alpha-Reductase Genes
JA Ellis, M Stebbing, SB Harrap
Journal of Investigative Dermatology 1998
Predominance of type I 5alpha-reductase in apocrine sweat glands of patients with excessive or abnormal odour derived from apocrine sweat (osmidrosis)
Sato, Sonoda, Itami, Takayasu
British Journal of Dermatology 1998
LOCALIZATION BY IN SITU HYBRIDIZATION OF STEROID 5 alpha-REDUCTASE ISOZYME GENE EXPRESSION IN THE HUMAN PROSTATE AND PREPUTIAL SKIN
G Pelletier, V Luu-The, XF Huang, H Lapointe, F Labrie
The Journal of Urology 1998
Presence of 5α-Reductase isozymes and aromatase in human prostate cancer cells and in benign prostate hyperplastic tissue
P Negri-Cesi, A Poletti, A Colciago, P Magni, P Martini, M Motta
The Prostate 1998
5α-reductase and 17β-hydroxysteroid dehydrogenase expression in epithelial cells from hyperplastic and malignant human prostate
S Délos, JL Carsol, F Fina, JP Raynaud, PM Martin
International Journal of Cancer 1998
Erectile dysfunction following treatments of benign prostatic hyperplasia: A prospective study
MC Uygur, E Gür, AI Arik, U Altuǧ, D Erol
Andrologia 1998
Endocrine and adrenergic pharmacological intervention in diseases of the prostate
A Rane
British Journal of Clinical Pharmacology 1998
Effects of the 5α-Reductase Inhibitor Finasteride on Serum Levels of Gonadal, Adrenal, and Hypophyseal Hormones and its Clinical Significance: A Prospective Clinical Study
MC Uygur, Aİ Arık, U Altuğ, D Erol
Steroids 1998
PNU 157706, a novel dual type I and II5α-reductase inhibitor
E Salle, D Giudici, A Radice, T Zaccheo, G Ornati, M Nesi, A Panzeri, S Délos, PM Martin
The Journal of Steroid Biochemistry and Molecular Biology 1998
Association of Benign Prostatic Hyperplasia with Male Pattern Baldness
BR Oh, SJ Kim, JD Moon, HN Kim, DD Kwon, YH Won, SB Ryu, YI Park
Urology 1998
Advances in Protein Chemistry
CM Silva, J Isgaard, MO Thorner
Advances in Protein Chemistry 1998
DISORDERS OF SEXUAL DIFFERENTIATION
GL Warne, JD Zajac
Endocrinology and metabolism clinics of North America 1998
Proscar@ (Finasteride) inhibits 5α-reductase activity in the ovaries and testes of Lytechinus variegatus Lamarck (Echinodermata: Echinoidea)
KM Wasson, SA Watts
Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology 1998
Natural potent androgens: Lessons from human genetic models
Y Zhu, MD Katz, J Imperato-McGinley
Baillière's Clinical Endocrinology and Metabolism 1998
Effect of finasteride in idiopathic hirsutism
E Faloia, S Filipponi, V Mancini, SD Marco, F Mantero
Journal of Endocrinological Investigation 1998
Evidence of Heterogeneity and Quantitative Differences of the Type 1 5α-Reductase Expression in Cultured Human Skin Cells – Evidence of its Presence in Melanocytes
W Chen, CC Zouboulis, M Fritsch, U Blume-Peytavi, V Kodelja, S Goerdt, V Luu-The, CE Orfanos
Journal of Investigative Dermatology 1998
cDNA Cloning of Mouse and Human Cholesterol 25-Hydroxylases, Polytopic Membrane Proteins That Synthesize a Potent Oxysterol Regulator of Lipid Metabolism
EG Lund, TA Kerr, J Sakai, WP Li, DW Russell
The Journal of biological chemistry 1998
Endocrinology of Pregnancy
FW Bazer
1998
Molecular Basis of Sex Hormone Receptor Function
H Gronemeyer, U Fuhrmann, K Parczyk
1998
Luteinizing Hormone and Human Chorionic Gonadotropin Decrease Type 2 5α-Reductase and Androgen Receptor Protein Levels in Women’s Skin
J Bird, X Li, ZM Lei, J Sanfilippo, MA Yussman, CV Rao
The Journal of clinical endocrinology and metabolism 1998
Marked reduction in bile acid synthesis in cholesterol 7α-hydroxylase-deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia
M Schwarz, DW Russell, JM Dietschy, SD Turley
Journal of lipid research 1998
Expression of 5α-Reductase in the Human Temporal Lobe of Children and Adults1
B Stoffel-Wagner, M Watzka, S Steckelbroeck, L Wickert, J Schramm, G Romalo, D Klingmüller, HU Schweikert
The Journal of clinical endocrinology and metabolism 1998
Inhibitory Effects of Serenoa repens on the Kinetic of Pig Prostatic Microsomal 5α-Reductase Activity
MF Palin, M Faguy, JG LeHoux, G Pelletier
Endocrine 1998
Topical finasteride in the treatment of androgenic alopecia. Preliminary evaluations after a 16-month therapy course
GF Mazzarella, GF Loconsole, GA Cammisa, GM Mastrolonardo, G Vena
Journal of Dermatological Treatment 1997
Activity of type 1 5α–reductase is greater in the follicular infrainfundibulum compared with the epidermis
D Thiboutot, H Knaggs, K Gilliland, S Hagari
British Journal of Dermatology 1997
Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta)
S Prahalada, AF Tarantal, GS Harris, KP Ellsworth, AP Clarke, GL Skiles, KI MacKenzie, LF Kruk, DS Ablin, MA Cukierski, CP Peter, MJ vanZwieten, AG Hendrickx
Teratology 1997
Different Levels of 5alpha-Reductase Type I and II, Aromatase, and Androgen Receptor in Hair Follicles of Women and Men with Androgenetic Alopecia
ME Sawaya, VH Price
Journal of Investigative Dermatology 1997
Pharmacological and molecular evidence for the expression of the two steroid 5α-reductase isozymes in normal and hyperplastic human prostatic cells in culture
I Berthaut, C Mestayer, MC Portois, O Cussenot, I Mowszowicz
The Prostate 1997
Steroid 5α-reductase inhibitors in androgen-dependent disorders
GS Harris, JW Kozarich
Current Opinion in Chemical Biology 1997
Identification of two novel cis-elements in the promoter of the prostate-specific antigen gene that are required to enhance androgen receptor-mediated transactivation
J Zhang, S Zhang, PE Murtha, W Zhu, SS Hou, CY Young
Nucleic Acids Research 1997
Steroid Metabolism in the Mammalian Brain: 5Alpha-Reduction and Aromatization
F Celotti, P Negri-Cesi, A Poletti
Brain Research Bulletin 1997
Inhibition of rat α-reductases by finasteride: Evidence for isozyme differences in the mechanism of inhibition
B Azzolina, K Ellsworth, S Andersson, W Geissler, HG Bull, GS Harris
The Journal of Steroid Biochemistry and Molecular Biology 1997
Male pseudohermaphroditism due to 5 alpha-reductase-2 deficiency in an Arab kindred
HM al-Attia
Postgraduate medical journal 1997
Male Infertility and Sexual Dysfunction
WJ Hellstrom
1997
Preputial Sebocyte 5α-Reductase Isoform Specificity*
D Deplewski, S Liao, RL Rosenfield
Endocrinology 1997
Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis
D Thiboutot, H Knaggs, K Gilliland, S Hagari
British Journal of Dermatology 1997
Differential Gene Expression of Steroid 5α-Reductase 2 in Core Needle Biopsies from Malignant and Benign Prostatic Tissue1
C Bjelfman, TG Söderström, E Brekkan, BJ Norlén, L Egevad, T Unge, S Andersson, A Rane
The Journal of clinical endocrinology and metabolism 1997
Benign Prostatic Hyperplasia: Practical Treatment Guidelines
T Tammela
Drugs & Aging 1997
Role of dihydrotestosterone in androgen action
JD Wilson
The Prostate 1996
Male Pseudohermaphroditism Due to Steroid 5 alpha-Reductase 2 Deficiency
BB Mendonca, M Inacio, EM Costa, IJ Arnhold, FA Silva, W Nicolau, W Bloise, DW Russell, JD Wilson
Medicine 1996
Immunohistochemical Analysis of Steroid 5?-Reductase Type 1 in Human Scalp and Prostate
S Patel, M Einstein, W Geissler, L Wu, S Andersson
Annals of the New York Academy of Sciences 1996
The development of non-steroidal dual inhibitors of both human 5α-reductase isozymes
J Blagg, SA Ballard, K Cooper, PW Finn, PS Johnson, F MacIntyre, GN Maw, PL Spargo
Bioorganic & Medicinal Chemistry Letters 1996
Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5α-reductase inhibitor
DM Sutkowski, JE Audia, RL Goode, KC Hsiao, IY Leibovitch, AM McNulty, BL Neubauer
The Prostate 1996
ANTIANDROGEN THERAPY IN DERMATOLOGY
JC Shaw
International Journal of Dermatology 1996
Synthesis of 4,17-diazasteroid inhibitors of human 5α-reductase
JW Morzycki, Z z.xl;Lotowski, AZ Wilczewska, JD Stuart
Bioorganic & Medicinal Chemistry 1996
Immunochemical detection of 5α-reductase in human serum
ME Lombardo, PB Hudson
Steroids 1996
Kinetic analysis of rat steroid 5α-reductase activity in prostate and epididymis homogenates at neutral pH: Evidence for type I activity in epididymis
PN Span, TJ Benraad, CG Sweep, AG Smals
The Journal of Steroid Biochemistry and Molecular Biology 1996
Kinetic analysis of steroid 5α-reductase activity at neutral pH in benign prostatic hyperplastic tissue: Evidence for type I isozyme activity in the human prostate
PN Span, TJ Benraad, CG Sweep, AG Smals
The Journal of Steroid Biochemistry and Molecular Biology 1996
Characterization of 5α-reductase gene expression in stroma and epithelium of human prostate
N Bruchovsky, MD Sadar, K Akakura, SL Goldenberg, K Matsuoka, PS Rennie
The Journal of Steroid Biochemistry and Molecular Biology 1996
FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
D Giudici, G Briatico, C Cominato, T Zaccheo, C Iehlè, M Nesi, A Panzeri, E Salle
The Journal of Steroid Biochemistry and Molecular Biology 1996
Characterization of type I 5α-reductase activity in DU145 human prostatic adenocarcinoma cells
M Kaefer, JE Audia, N Bruchovsky, RL Goode, KC Hsiao, IY Leibovitch, JH Krushinski, C Lee, CP Steidle, DM Sutkowski, BL Neubauer
The Journal of Steroid Biochemistry and Molecular Biology 1996
MK386: a potent, selective inhibitor of the human type 1 5α-reductase
K Ellsworth, B Azzolina, W Baginsky, H Bull, B Chang, G Cimis, S Mitra, J Toney, RK Bakshi, GR Rasmusson, RL Tolman, GS Harris
The Journal of Steroid Biochemistry and Molecular Biology 1996
Acne
GF Webster
Current Problems in Dermatology 1996
ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
JC Shaw
Dermatologic Clinics 1996
Metabolism of steroids in the brain: a new insight into the role of 5α-reductase and aromatase in brain differentiation and functions
P Negri-Cesi, A Poletti, F Celotti
The Journal of Steroid Biochemistry and Molecular Biology 1996
In Vivo Time-Dependent Inhibition of Human Steroid 5a-Reductase by Finasteride
G Tian
Journal of Pharmaceutical Sciences 1996
Finasteride**Proscar; Merck, Sharp, and Dohme, Rahway, New Jersey. in the treatment of hirsutism: new therapeutic perspectives
A Tolino, A Petrone, F Sarnacchiaro, D Cirillo, S Ronsini, G Lombardi, C Nappi
Fertility and Sterility 1996
Outcome of long-term treatment with the 5α-reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up**Supported by grants from the Consiglio Nazionale delle Ricerche (INV 963687) and the Italian Ministry of Higher Education and Scientific Research
R Castello, F Tosi, F Perrone, C Negri, M Muggeo, P Moghetti
Fertility and Sterility 1996
5α-Reductases and Their Inhibitors
G Spera, C Lubrano
International journal of immunopathology and pharmacology 1996
Testosterone metabolism in primary cultures of epithelial cells and stroma from benign prostatic hyperplasia
M Tsugaya, FK Habib, GD Chisholm, M Ross, K Tozawa, Y Hayashi, K Kohri, S Tanaka
Urological Research 1996
Carcinoma of the Prostate
Z Petrovich, L Baert, LW Brady
1996
Serenoa repens (Permixon®): A Review of its Pharmacology and Therapeutic Efficacy in Benign Prostatic Hyperplasia
GL Plosker, RN Brogden
Drugs & Aging 1996
Activity of the Type 1 5alpha-Reductase Exhibits Regional Differences in Isolated Sebaceous Glands and Whole Skin
D Thiboutot, G Harris, V Iles, G Cimis, K Gilliland, S Hagari
Journal of Investigative Dermatology 1995
Disorders of sexual development
JD Zajac, GL Warne
Baillière's Clinical Endocrinology and Metabolism 1995
Cations Inhibit Specifically Type I 5alpha-Reductase Found in Human Skin
Y Sugimoto, I Lopez-Solache, F Labrie, V Luu-The
Journal of Investigative Dermatology 1995
Activin and inhibin have opposite effects on steroid 5α-reductase activity in genital skin fibroblasts
I Antonipillai, M Wahe, J Yamamoto, R Horton
Molecular and Cellular Endocrinology 1995
Human fetal adrenal hydroxysteroid sulphotransferase: cDNA cloning, stable expression in V79 cells and functional characterisation of the expressed enzyme
KJ Forbes, M Hagen, H Glatt, R Hume, MW Coughtrie
Molecular and Cellular Endocrinology 1995
The enzyme and inhibitors of 4-ene-3-oxosteroid 5α-oxidoreductase
X Li, C Chen, SM Singh, F Labire
Steroids 1995
Cloning, expression and functional characterization of type 1 and type 2 steroid 5α-reductases from Cynomolgus monkey: Comparisons with human and rat isoenzymes
MA Levy, M Brandt, KM Sheedy, DA Holt, JI Heaslip, JJ Trill, PJ Ryan, RA Morris, LM Garrison, DJ Bergsma
The Journal of Steroid Biochemistry and Molecular Biology 1995
Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts
S De´los, JL Carsol, E Ghazarossian, JP Raynaud, PM Martin
The Journal of Steroid Biochemistry and Molecular Biology 1995
Rat steroid 5α-reductase kinetic characteristics: Extreme pH-dependency of the type II isozyme in prostate and epididymis homogenates
PN Span, AG Smals, CG Sweep, TJ Benraad
The Journal of Steroid Biochemistry and Molecular Biology 1995
FK143, a novel nonsteroidal inhibitor of steroid 5α-reductase: (1) In vitro effects on human and animal prostatic enzymes
J Hirosumi, O Nakayama, T Fagan, K Sawada, N Chida, M Inami, S Takahashi, H Kojo, Y Notsu, M Okuhara
The Journal of Steroid Biochemistry and Molecular Biology 1995
Human prostatic steroid 5α-reductase isoforms—A comparative study of selective inhibitors
C Iehlé, S Délos, O Guirou, R Tate, JP Raynaud, PM Martin
The Journal of Steroid Biochemistry and Molecular Biology 1995
Synthesis of 6-azacholesten-3-ones: Potent inhibitors of 5α-reductase
C Haffner
Tetrahedron Letters 1995
Androgenetic alopecia: An autosomal dominant disorder
WF Bergfeld
The American Journal of Medicine 1995
Role of androgens in the developmental biology of the pilosebaceous unit
RL Rosenfield, D Deplewski
The American Journal of Medicine 1995
Benign prostatic hyperplasia
WD Steers, B Zorn
Disease-a-Month 1995
BENIGN PROSTATIC HYPERPLASIA
JD McConnell
The Urologic clinics of North America 1995
5α-Reductase inhibitors and prostatic disease
FH Schröder
Clinical Endocrinology 1994
Male pseudohermaphroditism caused by mutations of testicular 17β–hydroxysteroid dehydrogenase 3
WM Geissler, DL Davis, L Wu, KD Bradshaw, S Patel, BB Mendonca, KO Elliston, JD Wilson, DW Russell, S Andersson
Nature Genetics 1994
5α-Réductases: Physiologie et pathologie
I Mowszowicz, I Berthaut, C Mestayer, F Wright, F Kuttenn, P Mauvais-Jarvis
Andrologie 1994
Purification of testosterone 5∝-reductase from human prostate by a four-step chromatographic procedure
E Quemener, Y Amet, S Stefano, G Fournier, HH Floch, JH Abalain
Steroids 1994
Finasteride
AJ Wood, RS Rittmaster
New England Journal of Medicine 1994
9 Role of 5α-reductase in health and disease
VA Randall
Baillière's Clinical Endocrinology and Metabolism 1994
Pretranslational down-regulation of male specific hepatic P450s after portal bypass
J Xing-Mai, E Cantrill, GC Farrell, M Murray
Biochemical Pharmacology 1994
17.beta.-(N-tert-Butylcarbamoyl)-4-aza-5.alpha.-androstan-1-en-3-one Is an Active Site-Directed Slow Time-Dependent Inhibitor of Human Steroid 5.alpha.-Reductase 1
G Tian, JD Stuart, ML Moss, PL Domanico, HN Bramson, IR Patel, SH Kadwell, LK Overton, TA Kost
Biochemistry 1994
Expression and Regulation of Steroid 5α-Reductase 2 in Prostate Disease
RI Silver, EL Wiley, DL Davis, AE Thigpen, DW Russell, JD Mcconnell
The Journal of Urology 1994
Endocrine Evaluation of Testicular Function
SJ Winters
Endocrinology and metabolism clinics of North America 1994
International Review of Cytology
RA Miller
International Review of Cytology 1991

← Previous 1 2 3 … 20 21 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 policy sources
Referenced in 3 patents
Referenced in 7 Wikipedia pages
153 readers on Mendeley
See more details